BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 50386959 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccc(F)cc1OC(C)C |wU:17.21,wD:14.14,(30.8,4.05,;29.26,4.06,;28.48,2.73,;26.92,2.73,;26.15,1.38,;26.91,.06,;28.47,.06,;29.23,1.38,;30.77,1.37,;31.54,.03,;26.14,-1.29,;24.82,-.52,;27.5,-2.06,;25.39,-2.59,;23.81,-2.59,;23.05,-1.28,;21.52,-1.24,;20.76,-2.56,;21.53,-3.91,;23.05,-3.91,;19.19,-2.56,;18.42,-3.89,;16.89,-3.89,;16.12,-2.54,;16.89,-1.21,;18.43,-1.24,;14.57,-2.54,;13.79,-3.88,;12.25,-3.88,;11.48,-2.53,;9.94,-2.52,;12.27,-1.21,;13.79,-1.21,;14.57,.13,;13.79,1.47,;14.56,2.8,;12.25,1.47,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-27-17-21(29)5-11-25(27)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-26(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 FEQSGCAJKJDTEE-UHFFFAOYSA-N 50213508 N-((1r,4r)-4-(4-(4-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228658 Alpha-1A adrenergic receptor Homo sapiens 23 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213508&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857863 104088857 CHEMBL228658 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386960 FC(F)Oc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.76,-7.54,;9.98,-8.87,;10.75,-10.21,;8.44,-8.86,;7.67,-10.19,;6.11,-10.19,;5.34,-11.54,;6.1,-12.86,;7.66,-12.86,;8.42,-11.54,;5.33,-14.21,;4.01,-13.44,;6.69,-14.98,;4.57,-15.51,;3,-15.51,;2.24,-16.83,;.72,-16.83,;-.06,-15.48,;.71,-14.16,;2.24,-14.2,;-1.62,-15.48,;-2.39,-16.81,;-3.92,-16.81,;-4.69,-15.46,;-3.92,-14.13,;-2.39,-14.16,;-6.25,-15.46,;-7.02,-16.8,;-8.56,-16.8,;-9.33,-15.45,;-8.55,-14.13,;-7.02,-14.13,;-6.25,-12.78,;-7.02,-11.45,;-6.25,-10.12,;-5.49,-8.77,;-4.91,-10.88,;-7.59,-9.36,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-9-11-22(12-10-21)38(34,35)32-19-5-7-20(8-6-19)33-15-13-18(14-16-33)23-3-1-2-4-24(23)36-17-26(29,30)31/h1-4,9-12,18-20,25,32H,5-8,13-17H2 GAFGMUJBSNDSHX-UHFFFAOYSA-N 50213509 4-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL387832 Alpha-1A adrenergic receptor Homo sapiens 5.4 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213509&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426405 104088858 CHEMBL387832 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386961 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:15.19,wD:12.12,(31.96,-44.68,;31.18,-43.35,;31.94,-42.01,;31.16,-40.68,;29.61,-40.69,;28.82,-39.37,;28.85,-42.04,;29.64,-43.36,;28.88,-44.7,;27.52,-43.96,;30.22,-45.44,;28.16,-46.06,;26.62,-46.12,;25.8,-44.81,;24.25,-44.87,;23.54,-46.24,;24.37,-47.54,;25.9,-47.48,;22.01,-46.29,;21.29,-47.66,;19.76,-47.72,;18.93,-46.42,;19.64,-45.05,;21.18,-44.99,;17.39,-46.49,;16.68,-47.85,;15.14,-47.92,;14.31,-46.62,;15.02,-45.26,;16.56,-45.18,;17.26,-43.81,;16.43,-42.52,;16.36,-40.99,;15.06,-41.82,)| InChI=1S/C26H32ClFN2O3S/c27-19-5-12-24(28)26(17-19)34(31,32)29-20-6-8-21(9-7-20)30-15-13-18(14-16-30)23-3-1-2-4-25(23)33-22-10-11-22/h1-5,12,17-18,20-22,29H,6-11,13-16H2 LVDRNYWTLKUNNT-UHFFFAOYSA-N 50213510 5-chloro-N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-fluorobenzenesulfonamide::CHEMBL228332 Alpha-1D adrenergic receptor Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213510&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857711 104088859 CHEMBL228332 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386962 FC(F)Oc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.76,-7.54,;9.98,-8.87,;10.75,-10.21,;8.44,-8.86,;7.67,-10.19,;6.11,-10.19,;5.34,-11.54,;6.1,-12.86,;7.66,-12.86,;8.42,-11.54,;5.33,-14.21,;4.01,-13.44,;6.69,-14.98,;4.57,-15.51,;3,-15.51,;2.24,-16.83,;.72,-16.83,;-.06,-15.48,;.71,-14.16,;2.24,-14.2,;-1.62,-15.48,;-2.39,-16.81,;-3.92,-16.81,;-4.69,-15.46,;-3.92,-14.13,;-2.39,-14.16,;-6.25,-15.46,;-7.02,-16.8,;-8.56,-16.8,;-9.33,-15.45,;-8.55,-14.13,;-7.02,-14.13,;-6.25,-12.78,;-7.02,-11.45,;-6.25,-10.12,;-5.49,-8.77,;-4.91,-10.88,;-7.59,-9.36,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-9-11-22(12-10-21)38(34,35)32-19-5-7-20(8-6-19)33-15-13-18(14-16-33)23-3-1-2-4-24(23)36-17-26(29,30)31/h1-4,9-12,18-20,25,32H,5-8,13-17H2 GAFGMUJBSNDSHX-UHFFFAOYSA-N 50213509 4-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL387832 Alpha-1D adrenergic receptor Homo sapiens 2.7 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213509&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426405 104088858 CHEMBL387832 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386963 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:17.21,14.14,(10.4,-18.11,;8.86,-18.12,;8.11,-19.46,;6.55,-19.48,;5.8,-20.82,;6.58,-22.14,;8.13,-22.14,;8.89,-20.8,;10.43,-20.78,;11.21,-22.11,;5.82,-23.49,;4.47,-22.75,;7.17,-24.23,;5.1,-24.85,;3.57,-24.91,;2.85,-26.27,;1.31,-26.33,;.49,-25.02,;1.2,-23.66,;2.75,-23.6,;-1.04,-25.08,;-1.76,-26.44,;-3.29,-26.51,;-4.12,-25.21,;-3.41,-23.84,;-1.87,-23.78,;-5.66,-25.27,;-6.37,-26.64,;-7.91,-26.71,;-8.73,-25.41,;-8.03,-24.04,;-6.49,-23.97,;-5.79,-22.6,;-6.62,-21.31,;-6.69,-19.77,;-7.99,-20.6,)| InChI=1S/C28H38N2O5S/c1-33-27-14-13-24(19-28(27)34-2)36(31,32)29-21-7-9-22(10-8-21)30-17-15-20(16-18-30)25-5-3-4-6-26(25)35-23-11-12-23/h3-6,13-14,19-23,29H,7-12,15-18H2,1-2H3 JFRXSPVSGNWHOD-UHFFFAOYSA-N 50213511 N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL229085 Alpha-1D adrenergic receptor Homo sapiens 2 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213511&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11519153 104088860 CHEMBL229085 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386964 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:17.21,14.14,(10.4,-18.11,;8.86,-18.12,;8.11,-19.46,;6.55,-19.48,;5.8,-20.82,;6.58,-22.14,;8.13,-22.14,;8.89,-20.8,;10.43,-20.78,;11.21,-22.11,;5.82,-23.49,;4.47,-22.75,;7.17,-24.23,;5.1,-24.85,;3.57,-24.91,;2.85,-26.27,;1.31,-26.33,;.49,-25.02,;1.2,-23.66,;2.75,-23.6,;-1.04,-25.08,;-1.76,-26.44,;-3.29,-26.51,;-4.12,-25.21,;-3.41,-23.84,;-1.87,-23.78,;-5.66,-25.27,;-6.37,-26.64,;-7.91,-26.71,;-8.73,-25.41,;-8.03,-24.04,;-6.49,-23.97,;-5.79,-22.6,;-6.62,-21.31,;-6.69,-19.77,;-7.99,-20.6,)| InChI=1S/C28H38N2O5S/c1-33-27-14-13-24(19-28(27)34-2)36(31,32)29-21-7-9-22(10-8-21)30-17-15-20(16-18-30)25-5-3-4-6-26(25)35-23-11-12-23/h3-6,13-14,19-23,29H,7-12,15-18H2,1-2H3 JFRXSPVSGNWHOD-UHFFFAOYSA-N 50213511 N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL229085 D(2) dopamine receptor Homo sapiens 144 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213511&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11519153 104088860 CHEMBL229085 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50386965 FC(F)Oc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.76,-7.54,;9.98,-8.87,;10.75,-10.21,;8.44,-8.86,;7.67,-10.19,;6.11,-10.19,;5.34,-11.54,;6.1,-12.86,;7.66,-12.86,;8.42,-11.54,;5.33,-14.21,;4.01,-13.44,;6.69,-14.98,;4.57,-15.51,;3,-15.51,;2.24,-16.83,;.72,-16.83,;-.06,-15.48,;.71,-14.16,;2.24,-14.2,;-1.62,-15.48,;-2.39,-16.81,;-3.92,-16.81,;-4.69,-15.46,;-3.92,-14.13,;-2.39,-14.16,;-6.25,-15.46,;-7.02,-16.8,;-8.56,-16.8,;-9.33,-15.45,;-8.55,-14.13,;-7.02,-14.13,;-6.25,-12.78,;-7.02,-11.45,;-6.25,-10.12,;-5.49,-8.77,;-4.91,-10.88,;-7.59,-9.36,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-9-11-22(12-10-21)38(34,35)32-19-5-7-20(8-6-19)33-15-13-18(14-16-33)23-3-1-2-4-24(23)36-17-26(29,30)31/h1-4,9-12,18-20,25,32H,5-8,13-17H2 GAFGMUJBSNDSHX-UHFFFAOYSA-N 50213509 4-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL387832 Alpha-1B adrenergic receptor Homo sapiens 76 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213509&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426405 104088858 CHEMBL387832 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50386966 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:16.20,13.13,(10.04,-34.29,;8.5,-34.3,;7.72,-32.97,;8.48,-31.63,;7.7,-30.3,;6.15,-30.32,;5.37,-29,;5.4,-31.66,;6.18,-32.98,;5.42,-34.32,;4.07,-33.59,;6.77,-35.07,;4.7,-35.69,;3.16,-35.74,;2.44,-37.1,;.91,-37.16,;.09,-35.86,;.8,-34.5,;2.34,-34.44,;-1.45,-35.92,;-2.16,-37.28,;-3.7,-37.35,;-4.52,-36.05,;-3.82,-34.68,;-2.28,-34.62,;-6.06,-36.11,;-6.77,-37.48,;-8.31,-37.55,;-9.14,-36.24,;-8.43,-34.88,;-6.9,-34.81,;-6.19,-33.44,;-7.02,-32.14,;-7.1,-30.6,;-8.39,-31.43,)| InChI=1S/C27H35ClN2O4S/c1-33-26-13-6-20(28)18-27(26)35(31,32)29-21-7-9-22(10-8-21)30-16-14-19(15-17-30)24-4-2-3-5-25(24)34-23-11-12-23/h2-6,13,18-19,21-23,29H,7-12,14-17H2,1H3 CQABPCACTMBCQC-UHFFFAOYSA-N 50213512 5-chloro-N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-methoxybenzenesulfonamide::CHEMBL388897 Alpha-1A adrenergic receptor Homo sapiens 1.3 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213512&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857710 104088861 CHEMBL388897 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386967 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:17.21,wD:14.14,(32.87,-18.24,;31.33,-18.26,;30.57,-19.6,;29.02,-19.61,;28.27,-20.96,;29.05,-22.28,;30.59,-22.27,;31.35,-20.93,;32.89,-20.92,;33.67,-22.24,;28.29,-23.62,;26.94,-22.88,;29.64,-24.36,;27.57,-24.98,;26.03,-25.04,;25.21,-23.74,;23.67,-23.79,;22.96,-25.16,;23.78,-26.46,;25.31,-26.4,;21.42,-25.21,;20.7,-26.58,;19.17,-26.64,;18.34,-25.34,;19.05,-23.98,;20.59,-23.91,;16.81,-25.41,;16.09,-26.78,;14.55,-26.84,;13.73,-25.54,;14.43,-24.18,;15.97,-24.1,;16.67,-22.73,;15.84,-21.44,;15.77,-19.91,;14.47,-20.74,)| InChI=1S/C28H38N2O5S/c1-33-27-14-13-24(19-28(27)34-2)36(31,32)29-21-7-9-22(10-8-21)30-17-15-20(16-18-30)25-5-3-4-6-26(25)35-23-11-12-23/h3-6,13-14,19-23,29H,7-12,15-18H2,1-2H3 JFRXSPVSGNWHOD-UHFFFAOYSA-N 50213513 N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228278 Alpha-1A adrenergic receptor Homo sapiens 11 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213513&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11519153 104088862 CHEMBL228278 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386968 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:16.20,wD:13.13,(32.85,-34.59,;31.31,-34.6,;30.53,-33.27,;31.29,-31.93,;30.5,-30.6,;28.95,-30.62,;28.17,-29.3,;28.2,-31.96,;28.98,-33.28,;28.22,-34.62,;26.87,-33.89,;29.57,-35.37,;27.5,-35.99,;25.97,-36.04,;25.14,-34.74,;23.6,-34.8,;22.89,-36.16,;23.71,-37.46,;25.24,-37.4,;21.35,-36.22,;20.64,-37.58,;19.11,-37.65,;18.28,-36.35,;18.98,-34.98,;20.53,-34.92,;16.74,-36.41,;16.03,-37.78,;14.49,-37.85,;13.66,-36.54,;14.37,-35.18,;15.9,-35.11,;16.61,-33.74,;15.78,-32.44,;15.7,-30.91,;14.41,-31.74,)| InChI=1S/C27H35ClN2O4S/c1-33-26-13-6-20(28)18-27(26)35(31,32)29-21-7-9-22(10-8-21)30-16-14-19(15-17-30)24-4-2-3-5-25(24)34-23-11-12-23/h2-6,13,18-19,21-23,29H,7-12,14-17H2,1H3 CQABPCACTMBCQC-UHFFFAOYSA-N 50213514 5-chloro-N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-methoxybenzenesulfonamide::CHEMBL228279 Alpha-1D adrenergic receptor Homo sapiens 47 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213514&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857710 104088863 CHEMBL228279 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386969 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:16.20,wD:13.13,(33.93,-35.76,;32.39,-35.76,;31.62,-34.43,;32.38,-33.1,;31.63,-31.76,;30.07,-31.76,;29.3,-30.42,;29.3,-33.1,;30.06,-34.43,;29.29,-35.77,;27.97,-35.01,;30.65,-36.55,;28.53,-37.08,;26.96,-37.08,;26.2,-35.77,;24.67,-35.73,;23.9,-37.04,;24.68,-38.4,;26.2,-38.4,;22.33,-37.04,;21.57,-38.37,;20.04,-38.37,;19.26,-37.03,;20.03,-35.69,;21.57,-35.73,;17.71,-37.03,;16.94,-38.36,;15.4,-38.36,;14.62,-37.01,;15.41,-35.69,;16.93,-35.69,;17.71,-34.35,;16.94,-33.02,;17.71,-31.68,;18.47,-30.34,;19.05,-32.44,;16.37,-30.92,)| InChI=1S/C26H32ClF3N2O4S/c1-35-24-11-6-19(27)16-25(24)37(33,34)31-20-7-9-21(10-8-20)32-14-12-18(13-15-32)22-4-2-3-5-23(22)36-17-26(28,29)30/h2-6,11,16,18,20-21,31H,7-10,12-15,17H2,1H3 WDZOSSNSOBKEMP-UHFFFAOYSA-N 50213515 5-chloro-2-methoxy-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL390192 D(2) dopamine receptor Homo sapiens 82 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213515&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857792 104088864 CHEMBL390192 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50386970 FC(F)(F)COc1ccccc1C1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc2OCCOc2c1 |wU:18.19,21.26,(-5.05,-19.16,;-5.81,-20.51,;-4.47,-21.27,;-7.15,-19.75,;-6.58,-21.84,;-5.8,-23.18,;-6.58,-24.52,;-8.1,-24.52,;-8.89,-25.84,;-8.12,-27.19,;-6.58,-27.19,;-5.8,-25.85,;-4.25,-25.85,;-3.48,-27.2,;-1.95,-27.2,;-1.18,-25.87,;-1.94,-24.55,;-3.48,-24.52,;.39,-25.87,;1.16,-27.22,;2.68,-27.22,;3.44,-25.9,;2.68,-24.59,;1.15,-24.55,;5.02,-25.9,;5.77,-24.6,;4.45,-23.83,;7.13,-25.37,;6.54,-23.25,;5.78,-21.93,;6.55,-20.58,;8.11,-20.58,;8.89,-19.25,;10.43,-19.26,;11.19,-20.6,;10.41,-21.93,;8.86,-21.93,;8.1,-23.25,)| InChI=1S/C27H33F3N2O5S/c28-27(29,30)18-37-24-4-2-1-3-23(24)19-11-13-32(14-12-19)21-7-5-20(6-8-21)31-38(33,34)22-9-10-25-26(17-22)36-16-15-35-25/h1-4,9-10,17,19-21,31H,5-8,11-16,18H2 PPAIEDLGYFCKEB-UHFFFAOYSA-N 50213516 N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide::CHEMBL439197 Alpha-1D adrenergic receptor Homo sapiens 3 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213516&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857791 104088865 CHEMBL439197 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386971 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccc(F)cc1OC(C)C |wU:17.21,wD:14.14,(30.8,4.05,;29.26,4.06,;28.48,2.73,;26.92,2.73,;26.15,1.38,;26.91,.06,;28.47,.06,;29.23,1.38,;30.77,1.37,;31.54,.03,;26.14,-1.29,;24.82,-.52,;27.5,-2.06,;25.39,-2.59,;23.81,-2.59,;23.05,-1.28,;21.52,-1.24,;20.76,-2.56,;21.53,-3.91,;23.05,-3.91,;19.19,-2.56,;18.42,-3.89,;16.89,-3.89,;16.12,-2.54,;16.89,-1.21,;18.43,-1.24,;14.57,-2.54,;13.79,-3.88,;12.25,-3.88,;11.48,-2.53,;9.94,-2.52,;12.27,-1.21,;13.79,-1.21,;14.57,.13,;13.79,1.47,;14.56,2.8,;12.25,1.47,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-27-17-21(29)5-11-25(27)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-26(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 FEQSGCAJKJDTEE-UHFFFAOYSA-N 50213508 N-((1r,4r)-4-(4-(4-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228658 Alpha-1B adrenergic receptor Homo sapiens 639 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213508&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857863 104088857 CHEMBL228658 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50386972 O=S(=O)(N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1)c1ccc2OCOc2c1 |wU:7.10,4.3,(4.39,.82,;5.71,.06,;7.07,-.72,;4.95,-1.25,;3.38,-1.25,;2.62,-2.57,;1.1,-2.57,;.32,-1.21,;1.09,.1,;2.62,.06,;-1.24,-1.21,;-2.01,-2.54,;-3.54,-2.54,;-4.31,-1.2,;-3.54,.13,;-2.01,.1,;-5.86,-1.2,;-6.64,-2.53,;-8.18,-2.53,;-8.95,-1.18,;-8.16,.13,;-6.64,.13,;-5.86,1.48,;-6.63,2.82,;-6.63,4.36,;-7.97,3.59,;6.48,1.4,;5.71,2.72,;6.49,4.07,;8.04,4.07,;9.08,5.21,;10.49,4.57,;10.32,3.04,;8.8,2.72,;8.04,1.4,)| InChI=1S/C27H34N2O5S/c30-35(31,23-11-12-26-27(17-23)33-18-32-26)28-20-5-7-21(8-6-20)29-15-13-19(14-16-29)24-3-1-2-4-25(24)34-22-9-10-22/h1-4,11-12,17,19-22,28H,5-10,13-16,18H2 ZIIYCNPQTIYWFF-UHFFFAOYSA-N 50213517 N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzo[d][1,3]dioxole-5-sulfonamide::CHEMBL389104 Alpha-1B adrenergic receptor Homo sapiens 275 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213517&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426404 104088866 CHEMBL389104 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50386973 FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.92,.29,;9.38,.29,;8.6,-1.03,;8.62,1.63,;7.08,1.64,;6.32,2.99,;4.76,2.99,;3.99,1.64,;4.75,.32,;6.32,.32,;3.98,-1.02,;2.66,-.26,;5.34,-1.8,;3.23,-2.33,;1.65,-2.33,;.89,-3.65,;-.63,-3.65,;-1.4,-2.3,;-.64,-.98,;.9,-1.02,;-2.97,-2.3,;-3.74,-3.62,;-5.27,-3.62,;-6.04,-2.28,;-5.27,-.95,;-3.73,-.98,;-7.59,-2.28,;-8.37,-3.62,;-9.91,-3.62,;-10.68,-2.27,;-9.89,-.95,;-8.37,-.95,;-7.59,.4,;-8.37,1.73,;-7.6,3.07,;-6.84,4.41,;-6.26,2.3,;-8.94,3.83,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2 RVPGPLCUKORXKA-UHFFFAOYSA-N 50213520 3-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228496 Alpha-1D adrenergic receptor Homo sapiens 5.9 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213520&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857794 104088869 CHEMBL228496 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386974 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:16.20,13.13,(10.04,-34.29,;8.5,-34.3,;7.72,-32.97,;8.48,-31.63,;7.7,-30.3,;6.15,-30.32,;5.37,-29,;5.4,-31.66,;6.18,-32.98,;5.42,-34.32,;4.07,-33.59,;6.77,-35.07,;4.7,-35.69,;3.16,-35.74,;2.44,-37.1,;.91,-37.16,;.09,-35.86,;.8,-34.5,;2.34,-34.44,;-1.45,-35.92,;-2.16,-37.28,;-3.7,-37.35,;-4.52,-36.05,;-3.82,-34.68,;-2.28,-34.62,;-6.06,-36.11,;-6.77,-37.48,;-8.31,-37.55,;-9.14,-36.24,;-8.43,-34.88,;-6.9,-34.81,;-6.19,-33.44,;-7.02,-32.14,;-7.1,-30.6,;-8.39,-31.43,)| InChI=1S/C27H35ClN2O4S/c1-33-26-13-6-20(28)18-27(26)35(31,32)29-21-7-9-22(10-8-21)30-16-14-19(15-17-30)24-4-2-3-5-25(24)34-23-11-12-23/h2-6,13,18-19,21-23,29H,7-12,14-17H2,1H3 CQABPCACTMBCQC-UHFFFAOYSA-N 50213512 5-chloro-N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-methoxybenzenesulfonamide::CHEMBL388897 Alpha-1D adrenergic receptor Homo sapiens 2.6 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213512&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857710 104088861 CHEMBL388897 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386975 CC(C)Oc1ccccc1C1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc(F)c(F)c1 |wU:16.17,wD:19.24,(14.85,-7.42,;14.15,-8.79,;12.61,-8.86,;14.98,-10.08,;14.27,-11.45,;12.74,-11.52,;12.03,-12.89,;12.86,-14.19,;14.4,-14.12,;15.11,-12.75,;16.65,-12.69,;17.47,-13.99,;19,-13.92,;19.72,-12.56,;18.89,-11.26,;17.35,-11.32,;21.26,-12.5,;21.97,-11.14,;23.51,-11.08,;24.33,-12.39,;23.61,-13.75,;22.08,-13.81,;25.87,-12.33,;26.59,-10.97,;25.24,-10.23,;27.94,-11.71,;27.35,-9.62,;26.57,-8.3,;27.32,-6.96,;28.87,-6.94,;29.63,-5.6,;29.65,-8.28,;31.19,-8.26,;28.89,-9.62,)| InChI=1S/C26H34F2N2O3S/c1-18(2)33-26-6-4-3-5-23(26)19-13-15-30(16-14-19)21-9-7-20(8-10-21)29-34(31,32)22-11-12-24(27)25(28)17-22/h3-6,11-12,17-21,29H,7-10,13-16H2,1-2H3 NHRXMVNDSUMAIN-UHFFFAOYSA-N 50213518 3,4-difluoro-N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL229084 D(2) dopamine receptor Homo sapiens 79 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213518&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857639 104088867 CHEMBL229084 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50386976 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCCF |wU:17.21,wD:14.14,(31.66,-22.48,;30.12,-22.47,;29.34,-23.8,;27.78,-23.8,;27.01,-25.15,;27.77,-26.47,;29.33,-26.47,;30.09,-25.15,;31.63,-25.16,;32.4,-26.5,;27,-27.82,;25.68,-27.05,;28.36,-28.59,;26.24,-29.13,;24.67,-29.13,;23.91,-27.82,;22.38,-27.77,;21.61,-29.09,;22.39,-30.44,;23.91,-30.44,;20.04,-29.09,;19.28,-30.42,;17.75,-30.42,;16.97,-29.08,;17.74,-27.74,;19.28,-27.77,;15.42,-29.08,;14.64,-30.41,;13.1,-30.41,;12.33,-29.06,;13.12,-27.74,;14.64,-27.74,;15.42,-26.4,;14.65,-25.06,;15.42,-23.73,;14.65,-22.4,)| InChI=1S/C27H37FN2O5S/c1-33-26-12-11-23(19-27(26)34-2)36(31,32)29-21-7-9-22(10-8-21)30-16-13-20(14-17-30)24-5-3-4-6-25(24)35-18-15-28/h3-6,11-12,19-22,29H,7-10,13-18H2,1-2H3 NZOIFXLLVJGITJ-UHFFFAOYSA-N 50213519 N-((1r,4r)-4-(4-(2-(2-fluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228606 Alpha-1A adrenergic receptor Homo sapiens 69 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213519&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857861 104088868 CHEMBL228606 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386977 CC(C)Oc1ccccc1C1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc(F)c(F)c1 |wU:16.17,wD:19.24,(14.85,-7.42,;14.15,-8.79,;12.61,-8.86,;14.98,-10.08,;14.27,-11.45,;12.74,-11.52,;12.03,-12.89,;12.86,-14.19,;14.4,-14.12,;15.11,-12.75,;16.65,-12.69,;17.47,-13.99,;19,-13.92,;19.72,-12.56,;18.89,-11.26,;17.35,-11.32,;21.26,-12.5,;21.97,-11.14,;23.51,-11.08,;24.33,-12.39,;23.61,-13.75,;22.08,-13.81,;25.87,-12.33,;26.59,-10.97,;25.24,-10.23,;27.94,-11.71,;27.35,-9.62,;26.57,-8.3,;27.32,-6.96,;28.87,-6.94,;29.63,-5.6,;29.65,-8.28,;31.19,-8.26,;28.89,-9.62,)| InChI=1S/C26H34F2N2O3S/c1-18(2)33-26-6-4-3-5-23(26)19-13-15-30(16-14-19)21-9-7-20(8-10-21)29-34(31,32)22-11-12-24(27)25(28)17-22/h3-6,11-12,17-21,29H,7-10,13-16H2,1-2H3 NHRXMVNDSUMAIN-UHFFFAOYSA-N 50213518 3,4-difluoro-N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL229084 Alpha-1A adrenergic receptor Homo sapiens 1.4 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213518&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857639 104088867 CHEMBL229084 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386978 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:16.20,13.13,(10.72,-35.85,;9.18,-35.85,;8.41,-34.51,;9.17,-33.19,;8.41,-31.84,;6.86,-31.84,;6.08,-30.51,;6.08,-33.19,;6.85,-34.51,;6.08,-35.86,;4.75,-35.09,;7.44,-36.63,;5.32,-37.16,;3.75,-37.16,;2.99,-38.48,;1.47,-38.48,;.69,-37.13,;1.45,-35.81,;2.99,-35.86,;-.88,-37.13,;-1.65,-38.46,;-3.17,-38.46,;-3.95,-37.11,;-3.18,-35.78,;-1.64,-35.81,;-5.5,-37.11,;-6.28,-38.45,;-7.82,-38.45,;-8.59,-37.1,;-7.8,-35.78,;-6.28,-35.78,;-5.5,-34.44,;-6.27,-33.1,;-5.5,-31.77,;-4.75,-30.43,;-4.17,-32.53,;-6.84,-31.01,)| InChI=1S/C26H32ClF3N2O4S/c1-35-24-11-6-19(27)16-25(24)37(33,34)31-20-7-9-21(10-8-20)32-14-12-18(13-15-32)22-4-2-3-5-23(22)36-17-26(28,29)30/h2-6,11,16,18,20-21,31H,7-10,12-15,17H2,1H3 WDZOSSNSOBKEMP-UHFFFAOYSA-N 50213522 5-chloro-2-methoxy-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL442059 D(2) dopamine receptor Homo sapiens 69 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213522&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857792 104088871 CHEMBL442059 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50386979 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.42,6.24,;7.88,6.23,;7.12,4.89,;5.57,4.87,;4.82,3.53,;5.6,2.21,;7.14,2.22,;7.9,3.56,;9.44,3.57,;10.22,2.24,;4.84,.87,;3.49,1.6,;6.19,.12,;4.12,-.5,;2.58,-.55,;1.86,-1.91,;.33,-1.97,;-.49,-.67,;.22,.69,;1.76,.75,;-2.03,-.73,;-2.75,-2.09,;-4.28,-2.16,;-5.11,-.86,;-4.4,.51,;-2.86,.57,;-6.64,-.92,;-7.36,-2.29,;-8.9,-2.36,;-9.72,-1.05,;-9.02,.31,;-7.48,.38,;-6.78,1.75,;-7.61,3.05,;-6.9,4.41,;-9.15,2.97,)| InChI=1S/C28H40N2O5S/c1-20(2)35-26-8-6-5-7-25(26)21-15-17-30(18-16-21)23-11-9-22(10-12-23)29-36(31,32)24-13-14-27(33-3)28(19-24)34-4/h5-8,13-14,19-23,29H,9-12,15-18H2,1-4H3 ACYCBNFGNBHQEP-UHFFFAOYSA-N 50213521 N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL390129 D(2) dopamine receptor Homo sapiens 144 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213521&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857638 104088870 CHEMBL390129 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50386980 O=S(=O)(N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1)c1ccc2OCOc2c1 |wU:7.10,4.3,(4.39,.82,;5.71,.06,;7.07,-.72,;4.95,-1.25,;3.38,-1.25,;2.62,-2.57,;1.1,-2.57,;.32,-1.21,;1.09,.1,;2.62,.06,;-1.24,-1.21,;-2.01,-2.54,;-3.54,-2.54,;-4.31,-1.2,;-3.54,.13,;-2.01,.1,;-5.86,-1.2,;-6.64,-2.53,;-8.18,-2.53,;-8.95,-1.18,;-8.16,.13,;-6.64,.13,;-5.86,1.48,;-6.63,2.82,;-6.63,4.36,;-7.97,3.59,;6.48,1.4,;5.71,2.72,;6.49,4.07,;8.04,4.07,;9.08,5.21,;10.49,4.57,;10.32,3.04,;8.8,2.72,;8.04,1.4,)| InChI=1S/C27H34N2O5S/c30-35(31,23-11-12-26-27(17-23)33-18-32-26)28-20-5-7-21(8-6-20)29-15-13-19(14-16-29)24-3-1-2-4-25(24)34-22-9-10-22/h1-4,11-12,17,19-22,28H,5-10,13-16,18H2 ZIIYCNPQTIYWFF-UHFFFAOYSA-N 50213517 N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzo[d][1,3]dioxole-5-sulfonamide::CHEMBL389104 Alpha-1A adrenergic receptor Homo sapiens 16 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213517&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426404 104088866 CHEMBL389104 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386981 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)F |wU:17.21,14.14,(10.25,-37,;8.71,-36.99,;7.93,-38.32,;6.37,-38.32,;5.6,-39.66,;6.36,-40.99,;7.93,-40.99,;8.69,-39.66,;10.23,-39.67,;10.99,-41.01,;5.59,-42.33,;4.27,-41.57,;6.95,-43.11,;4.84,-43.64,;3.26,-43.64,;2.5,-44.96,;.98,-44.96,;.21,-43.6,;.97,-42.29,;2.51,-42.33,;-1.36,-43.6,;-2.13,-44.93,;-3.66,-44.93,;-4.43,-43.59,;-3.66,-42.25,;-2.12,-42.29,;-5.98,-43.59,;-6.76,-44.92,;-8.3,-44.92,;-9.07,-43.58,;-8.29,-42.25,;-6.76,-42.25,;-5.98,-40.91,;-6.76,-39.58,;-5.99,-38.24,;-6.76,-36.91,;-4.45,-38.24,)| InChI=1S/C27H36F2N2O5S/c1-34-25-12-11-22(17-26(25)35-2)37(32,33)30-20-7-9-21(10-8-20)31-15-13-19(14-16-31)23-5-3-4-6-24(23)36-18-27(28)29/h3-6,11-12,17,19-21,27,30H,7-10,13-16,18H2,1-2H3 QLLKZBYEHJGRHK-UHFFFAOYSA-N 50213523 N-((1s,4s)-4-(4-(2-(2,2-difluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL387833 Alpha-1D adrenergic receptor Homo sapiens 4.1 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213523&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857862 104088872 CHEMBL387833 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386982 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC(C)C |wU:17.21,wD:14.14,(30.34,5.31,;28.8,5.3,;28.05,3.95,;26.49,3.94,;25.74,2.59,;26.52,1.27,;28.07,1.28,;28.83,2.62,;30.37,2.64,;31.15,1.31,;25.76,-.07,;24.41,.67,;27.11,-.81,;25.04,-1.43,;23.51,-1.49,;22.68,-.18,;21.14,-.24,;20.43,-1.6,;21.25,-2.91,;22.79,-2.85,;18.9,-1.66,;18.18,-3.02,;16.65,-3.09,;15.82,-1.79,;16.53,-.42,;18.07,-.36,;14.28,-1.85,;13.57,-3.22,;12.03,-3.29,;11.2,-1.99,;11.91,-.62,;13.45,-.55,;14.15,.82,;13.32,2.11,;14.03,3.48,;11.78,2.04,)| InChI=1S/C28H40N2O5S/c1-20(2)35-26-8-6-5-7-25(26)21-15-17-30(18-16-21)23-11-9-22(10-12-23)29-36(31,32)24-13-14-27(33-3)28(19-24)34-4/h5-8,13-14,19-23,29H,9-12,15-18H2,1-4H3 ACYCBNFGNBHQEP-UHFFFAOYSA-N 50213524 N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL388361 D(2) dopamine receptor Homo sapiens 55 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213524&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857638 104088873 CHEMBL388361 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50386983 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.42,6.24,;7.88,6.23,;7.12,4.89,;5.57,4.87,;4.82,3.53,;5.6,2.21,;7.14,2.22,;7.9,3.56,;9.44,3.57,;10.22,2.24,;4.84,.87,;3.49,1.6,;6.19,.12,;4.12,-.5,;2.58,-.55,;1.86,-1.91,;.33,-1.97,;-.49,-.67,;.22,.69,;1.76,.75,;-2.03,-.73,;-2.75,-2.09,;-4.28,-2.16,;-5.11,-.86,;-4.4,.51,;-2.86,.57,;-6.64,-.92,;-7.36,-2.29,;-8.9,-2.36,;-9.72,-1.05,;-9.02,.31,;-7.48,.38,;-6.78,1.75,;-7.61,3.05,;-6.9,4.41,;-9.15,2.97,)| InChI=1S/C28H40N2O5S/c1-20(2)35-26-8-6-5-7-25(26)21-15-17-30(18-16-21)23-11-9-22(10-12-23)29-36(31,32)24-13-14-27(33-3)28(19-24)34-4/h5-8,13-14,19-23,29H,9-12,15-18H2,1-4H3 ACYCBNFGNBHQEP-UHFFFAOYSA-N 50213521 N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL390129 Alpha-1D adrenergic receptor Homo sapiens 0.77 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213521&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857638 104088870 CHEMBL390129 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386984 FC(F)Oc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(33.81,-7.51,;33.03,-8.83,;33.79,-10.17,;31.49,-8.82,;30.71,-10.15,;29.15,-10.15,;28.38,-11.5,;29.14,-12.82,;30.71,-12.82,;31.47,-11.5,;28.37,-14.17,;27.05,-13.4,;29.73,-14.94,;27.62,-15.47,;26.04,-15.47,;25.29,-14.16,;23.75,-14.12,;22.99,-15.44,;23.76,-16.79,;25.28,-16.79,;21.42,-15.44,;20.65,-16.77,;19.13,-16.77,;18.35,-15.42,;19.12,-14.09,;20.66,-14.12,;16.8,-15.42,;16.02,-16.76,;14.48,-16.76,;13.71,-15.41,;14.5,-14.09,;16.02,-14.09,;16.8,-12.75,;16.03,-11.41,;16.8,-10.08,;17.55,-8.73,;18.13,-10.84,;15.46,-9.32,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-9-11-22(12-10-21)38(34,35)32-19-5-7-20(8-6-19)33-15-13-18(14-16-33)23-3-1-2-4-24(23)36-17-26(29,30)31/h1-4,9-12,18-20,25,32H,5-8,13-17H2 GAFGMUJBSNDSHX-UHFFFAOYSA-N 50213526 4-(difluoromethoxy)-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228554 Alpha-1D adrenergic receptor Homo sapiens 86 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213526&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426405 104088875 CHEMBL228554 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386985 FC(F)(F)COc1ccccc1C1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc2OCCOc2c1 |wU:18.19,wD:21.26,(18.05,-19.16,;17.29,-20.51,;18.63,-21.27,;15.95,-19.75,;16.52,-21.84,;17.3,-23.18,;16.52,-24.52,;15,-24.52,;14.21,-25.84,;14.98,-27.19,;16.52,-27.19,;17.3,-25.85,;18.85,-25.85,;19.62,-27.2,;21.15,-27.2,;21.92,-25.87,;21.16,-24.55,;19.62,-24.52,;23.49,-25.87,;24.25,-24.55,;25.78,-24.59,;26.54,-25.9,;25.78,-27.22,;24.26,-27.22,;28.12,-25.9,;28.87,-24.6,;27.55,-23.83,;30.23,-25.37,;29.64,-23.25,;28.88,-21.93,;29.65,-20.58,;31.21,-20.58,;31.99,-19.25,;33.53,-19.26,;34.29,-20.6,;33.51,-21.93,;31.96,-21.93,;31.2,-23.25,)| InChI=1S/C27H33F3N2O5S/c28-27(29,30)18-37-24-4-2-1-3-23(24)19-11-13-32(14-12-19)21-7-5-20(6-8-21)31-38(33,34)22-9-10-25-26(17-22)36-16-15-35-25/h1-4,9-10,17,19-21,31H,5-8,11-16,18H2 PPAIEDLGYFCKEB-UHFFFAOYSA-N 50213527 N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide::CHEMBL228390 D(2) dopamine receptor Homo sapiens 23 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213527&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857791 104088876 CHEMBL228390 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50386986 CC(C)Oc1ccccc1C1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc(F)c(F)c1 |wU:16.17,19.24,(-7.13,-7.52,;-7.84,-8.89,;-9.38,-8.96,;-7.01,-10.18,;-7.71,-11.55,;-9.25,-11.62,;-9.96,-12.99,;-9.13,-14.29,;-7.59,-14.22,;-6.88,-12.85,;-5.34,-12.79,;-4.51,-14.09,;-2.98,-14.02,;-2.26,-12.66,;-3.09,-11.36,;-4.63,-11.42,;-.73,-12.6,;.09,-13.91,;1.63,-13.85,;2.35,-12.49,;1.52,-11.18,;-.02,-11.24,;3.88,-12.43,;4.6,-11.07,;3.25,-10.33,;5.95,-11.81,;5.36,-9.72,;4.58,-8.4,;5.34,-7.06,;6.89,-7.04,;7.64,-5.7,;7.67,-8.38,;9.21,-8.36,;6.91,-9.72,)| InChI=1S/C26H34F2N2O3S/c1-18(2)33-26-6-4-3-5-23(26)19-13-15-30(16-14-19)21-9-7-20(8-10-21)29-34(31,32)22-11-12-24(27)25(28)17-22/h3-6,11-12,17-21,29H,7-10,13-16H2,1-2H3 NHRXMVNDSUMAIN-UHFFFAOYSA-N 50213528 3,4-difluoro-N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL390184 D(2) dopamine receptor Homo sapiens 79 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213528&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857639 104088877 CHEMBL390184 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50386987 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.65,-7.4,;9.11,-7.39,;8.33,-8.72,;6.77,-8.72,;6,-10.07,;6.76,-11.39,;8.32,-11.39,;9.08,-10.07,;10.62,-10.08,;11.38,-11.42,;5.99,-12.74,;4.67,-11.97,;7.35,-13.51,;5.23,-14.04,;3.66,-14.04,;2.9,-15.36,;1.38,-15.36,;.6,-14.01,;1.37,-12.69,;2.9,-12.73,;-.96,-14.01,;-1.73,-15.34,;-3.26,-15.34,;-4.03,-13.99,;-3.26,-12.66,;-1.73,-12.69,;-5.59,-13.99,;-6.36,-15.33,;-7.9,-15.33,;-8.67,-13.98,;-7.89,-12.66,;-6.36,-12.66,;-5.59,-11.31,;-6.36,-9.98,;-5.59,-8.65,;-4.83,-7.3,;-4.25,-9.41,;-6.93,-7.89,)| InChI=1S/C27H35F3N2O5S/c1-35-25-12-11-22(17-26(25)36-2)38(33,34)31-20-7-9-21(10-8-20)32-15-13-19(14-16-32)23-5-3-4-6-24(23)37-18-27(28,29)30/h3-6,11-12,17,19-21,31H,7-10,13-16,18H2,1-2H3 USIWFTPEBGPOSA-UHFFFAOYSA-N 50213525 3,4-dimethoxy-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228334 Alpha-1A adrenergic receptor Homo sapiens 1.8 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213525&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857709 104088874 CHEMBL228334 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386988 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:16.20,wD:13.13,(32.85,-34.59,;31.31,-34.6,;30.53,-33.27,;31.29,-31.93,;30.5,-30.6,;28.95,-30.62,;28.17,-29.3,;28.2,-31.96,;28.98,-33.28,;28.22,-34.62,;26.87,-33.89,;29.57,-35.37,;27.5,-35.99,;25.97,-36.04,;25.14,-34.74,;23.6,-34.8,;22.89,-36.16,;23.71,-37.46,;25.24,-37.4,;21.35,-36.22,;20.64,-37.58,;19.11,-37.65,;18.28,-36.35,;18.98,-34.98,;20.53,-34.92,;16.74,-36.41,;16.03,-37.78,;14.49,-37.85,;13.66,-36.54,;14.37,-35.18,;15.9,-35.11,;16.61,-33.74,;15.78,-32.44,;15.7,-30.91,;14.41,-31.74,)| InChI=1S/C27H35ClN2O4S/c1-33-26-13-6-20(28)18-27(26)35(31,32)29-21-7-9-22(10-8-21)30-16-14-19(15-17-30)24-4-2-3-5-25(24)34-23-11-12-23/h2-6,13,18-19,21-23,29H,7-12,14-17H2,1H3 CQABPCACTMBCQC-UHFFFAOYSA-N 50213514 5-chloro-N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-methoxybenzenesulfonamide::CHEMBL228279 Alpha-1A adrenergic receptor Homo sapiens 4.5 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213514&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857710 104088863 CHEMBL228279 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386989 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:15.19,12.12,(8.56,-46.34,;7.79,-45.01,;8.56,-43.69,;7.8,-42.34,;6.24,-42.34,;5.47,-41.01,;5.47,-43.69,;6.23,-45.01,;5.46,-46.35,;4.14,-45.59,;6.82,-47.13,;4.71,-47.66,;3.13,-47.66,;2.37,-48.98,;.85,-48.98,;.08,-47.63,;.84,-46.31,;2.37,-46.35,;-1.49,-47.63,;-2.26,-48.96,;-3.79,-48.96,;-4.56,-47.61,;-3.79,-46.28,;-2.26,-46.31,;-6.12,-47.61,;-6.89,-48.95,;-8.43,-48.95,;-9.2,-47.6,;-8.42,-46.28,;-6.89,-46.28,;-6.12,-44.93,;-6.89,-43.6,;-6.12,-42.27,;-5.36,-40.92,;-4.78,-43.03,;-7.46,-41.5,)| InChI=1S/C25H29ClF4N2O3S/c26-18-5-10-22(27)24(15-18)36(33,34)31-19-6-8-20(9-7-19)32-13-11-17(12-14-32)21-3-1-2-4-23(21)35-16-25(28,29)30/h1-5,10,15,17,19-20,31H,6-9,11-14,16H2 HNTIGZIKHBPAFD-UHFFFAOYSA-N 50213529 5-chloro-2-fluoro-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228445 Alpha-1B adrenergic receptor Homo sapiens 181 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213529&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857793 104088878 CHEMBL228445 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50386990 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1cc(F)ccc1OC(C)C |wU:17.21,14.14,(10.23,-7.86,;8.69,-7.85,;7.91,-9.18,;6.36,-9.18,;5.59,-10.53,;6.35,-11.85,;7.91,-11.85,;8.67,-10.53,;10.21,-10.54,;10.97,-11.88,;5.58,-13.19,;4.26,-12.43,;6.94,-13.97,;4.82,-14.5,;3.25,-14.5,;2.49,-15.82,;.97,-15.82,;.19,-14.47,;.96,-13.15,;2.49,-13.19,;-1.38,-14.47,;-2.14,-15.8,;-3.67,-15.8,;-4.45,-14.45,;-3.67,-13.12,;-2.14,-13.15,;-6,-14.45,;-6.77,-15.79,;-8.31,-15.79,;-9.08,-17.12,;-9.08,-14.44,;-8.3,-13.12,;-6.77,-13.12,;-6,-11.77,;-6.77,-10.44,;-6,-9.11,;-8.31,-10.44,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-26-11-5-21(29)17-25(26)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-27(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 AEJCTJSNUNXYQL-UHFFFAOYSA-N 50213530 N-((1s,4s)-4-(4-(5-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228659 Alpha-1A adrenergic receptor Homo sapiens 3.3 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213530&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857864 104088879 CHEMBL228659 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386991 FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(34.74,.1,;33.2,.11,;32.43,-1.22,;32.44,1.45,;30.9,1.46,;30.15,2.81,;28.59,2.81,;27.82,1.46,;28.58,.13,;30.14,.13,;27.81,-1.21,;26.49,-.44,;29.17,-1.98,;27.05,-2.51,;25.48,-2.51,;24.72,-1.21,;23.19,-1.16,;22.42,-2.48,;23.2,-3.83,;24.72,-3.83,;20.86,-2.48,;20.09,-3.81,;18.56,-3.81,;17.79,-2.46,;18.56,-1.13,;20.09,-1.16,;16.23,-2.46,;15.46,-3.8,;13.92,-3.8,;13.15,-2.45,;13.93,-1.13,;15.46,-1.13,;16.23,.21,;15.46,1.55,;16.23,2.88,;16.99,4.22,;17.57,2.12,;14.89,3.64,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2 RVPGPLCUKORXKA-UHFFFAOYSA-N 50213531 3-(difluoromethoxy)-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228553 Alpha-1A adrenergic receptor Homo sapiens 12 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213531&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857794 104088880 CHEMBL228553 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386992 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:17.21,14.14,(10.4,-18.11,;8.86,-18.12,;8.11,-19.46,;6.55,-19.48,;5.8,-20.82,;6.58,-22.14,;8.13,-22.14,;8.89,-20.8,;10.43,-20.78,;11.21,-22.11,;5.82,-23.49,;4.47,-22.75,;7.17,-24.23,;5.1,-24.85,;3.57,-24.91,;2.85,-26.27,;1.31,-26.33,;.49,-25.02,;1.2,-23.66,;2.75,-23.6,;-1.04,-25.08,;-1.76,-26.44,;-3.29,-26.51,;-4.12,-25.21,;-3.41,-23.84,;-1.87,-23.78,;-5.66,-25.27,;-6.37,-26.64,;-7.91,-26.71,;-8.73,-25.41,;-8.03,-24.04,;-6.49,-23.97,;-5.79,-22.6,;-6.62,-21.31,;-6.69,-19.77,;-7.99,-20.6,)| InChI=1S/C28H38N2O5S/c1-33-27-14-13-24(19-28(27)34-2)36(31,32)29-21-7-9-22(10-8-21)30-17-15-20(16-18-30)25-5-3-4-6-26(25)35-23-11-12-23/h3-6,13-14,19-23,29H,7-12,15-18H2,1-2H3 JFRXSPVSGNWHOD-UHFFFAOYSA-N 50213511 N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL229085 Alpha-1A adrenergic receptor Homo sapiens 0.91 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213511&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11519153 104088860 CHEMBL229085 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50386993 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccc(F)cc1OC(C)C |wU:17.21,14.14,(10.4,4.9,;8.86,4.91,;8.09,3.58,;6.53,3.58,;5.76,2.24,;6.52,.91,;8.08,.91,;8.84,2.23,;10.38,2.22,;11.14,.89,;5.75,-.43,;4.43,.33,;7.11,-1.21,;4.99,-1.74,;3.42,-1.74,;2.66,-3.06,;1.14,-3.06,;.36,-1.71,;1.13,-.39,;2.66,-.43,;-1.2,-1.71,;-1.97,-3.03,;-3.5,-3.03,;-4.27,-1.69,;-3.5,-.36,;-1.97,-.39,;-5.83,-1.69,;-6.6,-3.02,;-8.14,-3.02,;-8.91,-1.68,;-10.45,-1.66,;-8.13,-.36,;-6.6,-.36,;-5.83,.99,;-6.6,2.32,;-5.83,3.66,;-8.14,2.32,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-27-17-21(29)5-11-25(27)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-26(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 FEQSGCAJKJDTEE-UHFFFAOYSA-N 50213532 N-((1s,4s)-4-(4-(4-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228608 Alpha-1D adrenergic receptor Homo sapiens 12 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213532&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857863 104088881 CHEMBL228608 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386994 CCOc1ccccc1OCCN[C@H](C)Cc2ccc(c(c2)S(=O)(=O)N)OC InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24) DRHKJLXJIQTDTD-UHFFFAOYSA-N 50060964 5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide::(R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide::5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide::CHEMBL836::TAMSULOSIN Alpha-1D adrenergic receptor Homo sapiens 0.2 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060964 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060964&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search JGX 129211 103956570 CHEMBL836 DB00706 C07124 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386995 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccc(F)cc1OC(C)C |wU:17.21,wD:14.14,(30.8,4.05,;29.26,4.06,;28.48,2.73,;26.92,2.73,;26.15,1.38,;26.91,.06,;28.47,.06,;29.23,1.38,;30.77,1.37,;31.54,.03,;26.14,-1.29,;24.82,-.52,;27.5,-2.06,;25.39,-2.59,;23.81,-2.59,;23.05,-1.28,;21.52,-1.24,;20.76,-2.56,;21.53,-3.91,;23.05,-3.91,;19.19,-2.56,;18.42,-3.89,;16.89,-3.89,;16.12,-2.54,;16.89,-1.21,;18.43,-1.24,;14.57,-2.54,;13.79,-3.88,;12.25,-3.88,;11.48,-2.53,;9.94,-2.52,;12.27,-1.21,;13.79,-1.21,;14.57,.13,;13.79,1.47,;14.56,2.8,;12.25,1.47,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-27-17-21(29)5-11-25(27)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-26(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 FEQSGCAJKJDTEE-UHFFFAOYSA-N 50213508 N-((1r,4r)-4-(4-(4-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228658 Alpha-1D adrenergic receptor Homo sapiens 60 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213508&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857863 104088857 CHEMBL228658 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386996 FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(34.74,.1,;33.2,.11,;32.43,-1.22,;32.44,1.45,;30.9,1.46,;30.15,2.81,;28.59,2.81,;27.82,1.46,;28.58,.13,;30.14,.13,;27.81,-1.21,;26.49,-.44,;29.17,-1.98,;27.05,-2.51,;25.48,-2.51,;24.72,-1.21,;23.19,-1.16,;22.42,-2.48,;23.2,-3.83,;24.72,-3.83,;20.86,-2.48,;20.09,-3.81,;18.56,-3.81,;17.79,-2.46,;18.56,-1.13,;20.09,-1.16,;16.23,-2.46,;15.46,-3.8,;13.92,-3.8,;13.15,-2.45,;13.93,-1.13,;15.46,-1.13,;16.23,.21,;15.46,1.55,;16.23,2.88,;16.99,4.22,;17.57,2.12,;14.89,3.64,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2 RVPGPLCUKORXKA-UHFFFAOYSA-N 50213531 3-(difluoromethoxy)-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228553 Alpha-1D adrenergic receptor Homo sapiens 70 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213531&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857794 104088880 CHEMBL228553 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50386997 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCCF |wU:17.21,wD:14.14,(31.66,-22.48,;30.12,-22.47,;29.34,-23.8,;27.78,-23.8,;27.01,-25.15,;27.77,-26.47,;29.33,-26.47,;30.09,-25.15,;31.63,-25.16,;32.4,-26.5,;27,-27.82,;25.68,-27.05,;28.36,-28.59,;26.24,-29.13,;24.67,-29.13,;23.91,-27.82,;22.38,-27.77,;21.61,-29.09,;22.39,-30.44,;23.91,-30.44,;20.04,-29.09,;19.28,-30.42,;17.75,-30.42,;16.97,-29.08,;17.74,-27.74,;19.28,-27.77,;15.42,-29.08,;14.64,-30.41,;13.1,-30.41,;12.33,-29.06,;13.12,-27.74,;14.64,-27.74,;15.42,-26.4,;14.65,-25.06,;15.42,-23.73,;14.65,-22.4,)| InChI=1S/C27H37FN2O5S/c1-33-26-12-11-23(19-27(26)34-2)36(31,32)29-21-7-9-22(10-8-21)30-16-13-20(14-17-30)24-5-3-4-6-25(24)35-18-15-28/h3-6,11-12,19-22,29H,7-10,13-18H2,1-2H3 NZOIFXLLVJGITJ-UHFFFAOYSA-N 50213519 N-((1r,4r)-4-(4-(2-(2-fluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228606 D(2) dopamine receptor Homo sapiens 284 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213519&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857861 104088868 CHEMBL228606 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50386998 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccc(F)cc1OC(C)C |wU:17.21,14.14,(10.4,4.9,;8.86,4.91,;8.09,3.58,;6.53,3.58,;5.76,2.24,;6.52,.91,;8.08,.91,;8.84,2.23,;10.38,2.22,;11.14,.89,;5.75,-.43,;4.43,.33,;7.11,-1.21,;4.99,-1.74,;3.42,-1.74,;2.66,-3.06,;1.14,-3.06,;.36,-1.71,;1.13,-.39,;2.66,-.43,;-1.2,-1.71,;-1.97,-3.03,;-3.5,-3.03,;-4.27,-1.69,;-3.5,-.36,;-1.97,-.39,;-5.83,-1.69,;-6.6,-3.02,;-8.14,-3.02,;-8.91,-1.68,;-10.45,-1.66,;-8.13,-.36,;-6.6,-.36,;-5.83,.99,;-6.6,2.32,;-5.83,3.66,;-8.14,2.32,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-27-17-21(29)5-11-25(27)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-26(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 FEQSGCAJKJDTEE-UHFFFAOYSA-N 50213532 N-((1s,4s)-4-(4-(4-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228608 D(2) dopamine receptor Homo sapiens 106 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213532&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857863 104088881 CHEMBL228608 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50386999 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:15.19,12.12,(8.56,-46.34,;7.79,-45.01,;8.56,-43.69,;7.8,-42.34,;6.24,-42.34,;5.47,-41.01,;5.47,-43.69,;6.23,-45.01,;5.46,-46.35,;4.14,-45.59,;6.82,-47.13,;4.71,-47.66,;3.13,-47.66,;2.37,-48.98,;.85,-48.98,;.08,-47.63,;.84,-46.31,;2.37,-46.35,;-1.49,-47.63,;-2.26,-48.96,;-3.79,-48.96,;-4.56,-47.61,;-3.79,-46.28,;-2.26,-46.31,;-6.12,-47.61,;-6.89,-48.95,;-8.43,-48.95,;-9.2,-47.6,;-8.42,-46.28,;-6.89,-46.28,;-6.12,-44.93,;-6.89,-43.6,;-6.12,-42.27,;-5.36,-40.92,;-4.78,-43.03,;-7.46,-41.5,)| InChI=1S/C25H29ClF4N2O3S/c26-18-5-10-22(27)24(15-18)36(33,34)31-19-6-8-20(9-7-19)32-13-11-17(12-14-32)21-3-1-2-4-23(21)35-16-25(28,29)30/h1-5,10,15,17,19-20,31H,6-9,11-14,16H2 HNTIGZIKHBPAFD-UHFFFAOYSA-N 50213529 5-chloro-2-fluoro-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228445 D(2) dopamine receptor Homo sapiens 78 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213529&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857793 104088878 CHEMBL228445 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387000 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)F |wU:17.21,14.14,(10.25,-37,;8.71,-36.99,;7.93,-38.32,;6.37,-38.32,;5.6,-39.66,;6.36,-40.99,;7.93,-40.99,;8.69,-39.66,;10.23,-39.67,;10.99,-41.01,;5.59,-42.33,;4.27,-41.57,;6.95,-43.11,;4.84,-43.64,;3.26,-43.64,;2.5,-44.96,;.98,-44.96,;.21,-43.6,;.97,-42.29,;2.51,-42.33,;-1.36,-43.6,;-2.13,-44.93,;-3.66,-44.93,;-4.43,-43.59,;-3.66,-42.25,;-2.12,-42.29,;-5.98,-43.59,;-6.76,-44.92,;-8.3,-44.92,;-9.07,-43.58,;-8.29,-42.25,;-6.76,-42.25,;-5.98,-40.91,;-6.76,-39.58,;-5.99,-38.24,;-6.76,-36.91,;-4.45,-38.24,)| InChI=1S/C27H36F2N2O5S/c1-34-25-12-11-22(17-26(25)35-2)37(32,33)30-20-7-9-21(10-8-20)31-15-13-19(14-16-31)23-5-3-4-6-24(23)36-18-27(28)29/h3-6,11-12,17,19-21,27,30H,7-10,13-16,18H2,1-2H3 QLLKZBYEHJGRHK-UHFFFAOYSA-N 50213523 N-((1s,4s)-4-(4-(2-(2,2-difluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL387833 Alpha-1B adrenergic receptor Homo sapiens 300 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213523&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857862 104088872 CHEMBL387833 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387001 CC(C)Oc1ccccc1C1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc(F)c(F)c1 |wU:16.17,19.24,(-7.13,-7.52,;-7.84,-8.89,;-9.38,-8.96,;-7.01,-10.18,;-7.71,-11.55,;-9.25,-11.62,;-9.96,-12.99,;-9.13,-14.29,;-7.59,-14.22,;-6.88,-12.85,;-5.34,-12.79,;-4.51,-14.09,;-2.98,-14.02,;-2.26,-12.66,;-3.09,-11.36,;-4.63,-11.42,;-.73,-12.6,;.09,-13.91,;1.63,-13.85,;2.35,-12.49,;1.52,-11.18,;-.02,-11.24,;3.88,-12.43,;4.6,-11.07,;3.25,-10.33,;5.95,-11.81,;5.36,-9.72,;4.58,-8.4,;5.34,-7.06,;6.89,-7.04,;7.64,-5.7,;7.67,-8.38,;9.21,-8.36,;6.91,-9.72,)| InChI=1S/C26H34F2N2O3S/c1-18(2)33-26-6-4-3-5-23(26)19-13-15-30(16-14-19)21-9-7-20(8-10-21)29-34(31,32)22-11-12-24(27)25(28)17-22/h3-6,11-12,17-21,29H,7-10,13-16H2,1-2H3 NHRXMVNDSUMAIN-UHFFFAOYSA-N 50213528 3,4-difluoro-N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL390184 Alpha-1B adrenergic receptor Homo sapiens 470 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213528&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857639 104088877 CHEMBL390184 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387002 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)F |wU:17.21,wD:14.14,(32.79,-36.92,;31.25,-36.91,;30.47,-38.24,;28.91,-38.24,;28.14,-39.59,;28.9,-40.91,;30.46,-40.91,;31.23,-39.59,;32.77,-39.6,;33.53,-40.94,;28.13,-42.25,;26.81,-41.49,;29.49,-43.03,;27.38,-43.56,;25.8,-43.56,;25.04,-42.25,;23.51,-42.21,;22.75,-43.53,;23.52,-44.88,;25.04,-44.88,;21.18,-43.53,;20.41,-44.86,;18.88,-44.86,;18.11,-43.51,;18.88,-42.18,;20.41,-42.21,;16.55,-43.51,;15.78,-44.85,;14.24,-44.85,;13.47,-43.5,;14.25,-42.18,;15.78,-42.18,;16.55,-40.83,;15.78,-39.5,;16.55,-38.16,;15.78,-36.83,;18.09,-38.16,)| InChI=1S/C27H36F2N2O5S/c1-34-25-12-11-22(17-26(25)35-2)37(32,33)30-20-7-9-21(10-8-20)31-15-13-19(14-16-31)23-5-3-4-6-24(23)36-18-27(28)29/h3-6,11-12,17,19-21,27,30H,7-10,13-16,18H2,1-2H3 QLLKZBYEHJGRHK-UHFFFAOYSA-N 50213533 N-((1r,4r)-4-(4-(2-(2,2-difluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228607 Alpha-1B adrenergic receptor Homo sapiens 681 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213533&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857862 104088882 CHEMBL228607 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387003 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:16.20,wD:13.13,(32.85,-34.59,;31.31,-34.6,;30.53,-33.27,;31.29,-31.93,;30.5,-30.6,;28.95,-30.62,;28.17,-29.3,;28.2,-31.96,;28.98,-33.28,;28.22,-34.62,;26.87,-33.89,;29.57,-35.37,;27.5,-35.99,;25.97,-36.04,;25.14,-34.74,;23.6,-34.8,;22.89,-36.16,;23.71,-37.46,;25.24,-37.4,;21.35,-36.22,;20.64,-37.58,;19.11,-37.65,;18.28,-36.35,;18.98,-34.98,;20.53,-34.92,;16.74,-36.41,;16.03,-37.78,;14.49,-37.85,;13.66,-36.54,;14.37,-35.18,;15.9,-35.11,;16.61,-33.74,;15.78,-32.44,;15.7,-30.91,;14.41,-31.74,)| InChI=1S/C27H35ClN2O4S/c1-33-26-13-6-20(28)18-27(26)35(31,32)29-21-7-9-22(10-8-21)30-16-14-19(15-17-30)24-4-2-3-5-25(24)34-23-11-12-23/h2-6,13,18-19,21-23,29H,7-12,14-17H2,1H3 CQABPCACTMBCQC-UHFFFAOYSA-N 50213514 5-chloro-N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-methoxybenzenesulfonamide::CHEMBL228279 Alpha-1B adrenergic receptor Homo sapiens 305 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213514&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857710 104088863 CHEMBL228279 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387004 CC(C)Oc1ccccc1C1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc(F)c(F)c1 |wU:16.17,wD:19.24,(14.85,-7.42,;14.15,-8.79,;12.61,-8.86,;14.98,-10.08,;14.27,-11.45,;12.74,-11.52,;12.03,-12.89,;12.86,-14.19,;14.4,-14.12,;15.11,-12.75,;16.65,-12.69,;17.47,-13.99,;19,-13.92,;19.72,-12.56,;18.89,-11.26,;17.35,-11.32,;21.26,-12.5,;21.97,-11.14,;23.51,-11.08,;24.33,-12.39,;23.61,-13.75,;22.08,-13.81,;25.87,-12.33,;26.59,-10.97,;25.24,-10.23,;27.94,-11.71,;27.35,-9.62,;26.57,-8.3,;27.32,-6.96,;28.87,-6.94,;29.63,-5.6,;29.65,-8.28,;31.19,-8.26,;28.89,-9.62,)| InChI=1S/C26H34F2N2O3S/c1-18(2)33-26-6-4-3-5-23(26)19-13-15-30(16-14-19)21-9-7-20(8-10-21)29-34(31,32)22-11-12-24(27)25(28)17-22/h3-6,11-12,17-21,29H,7-10,13-16H2,1-2H3 NHRXMVNDSUMAIN-UHFFFAOYSA-N 50213518 3,4-difluoro-N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL229084 Alpha-1B adrenergic receptor Homo sapiens 1385 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213518&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857639 104088867 CHEMBL229084 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387005 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1cc(F)ccc1OC(C)C |wU:17.21,14.14,(10.23,-7.86,;8.69,-7.85,;7.91,-9.18,;6.36,-9.18,;5.59,-10.53,;6.35,-11.85,;7.91,-11.85,;8.67,-10.53,;10.21,-10.54,;10.97,-11.88,;5.58,-13.19,;4.26,-12.43,;6.94,-13.97,;4.82,-14.5,;3.25,-14.5,;2.49,-15.82,;.97,-15.82,;.19,-14.47,;.96,-13.15,;2.49,-13.19,;-1.38,-14.47,;-2.14,-15.8,;-3.67,-15.8,;-4.45,-14.45,;-3.67,-13.12,;-2.14,-13.15,;-6,-14.45,;-6.77,-15.79,;-8.31,-15.79,;-9.08,-17.12,;-9.08,-14.44,;-8.3,-13.12,;-6.77,-13.12,;-6,-11.77,;-6.77,-10.44,;-6,-9.11,;-8.31,-10.44,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-26-11-5-21(29)17-25(26)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-27(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 AEJCTJSNUNXYQL-UHFFFAOYSA-N 50213530 N-((1s,4s)-4-(4-(5-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228659 Alpha-1B adrenergic receptor Homo sapiens 299 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213530&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857864 104088879 CHEMBL228659 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387006 FC(F)Oc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(33.81,-7.51,;33.03,-8.83,;33.79,-10.17,;31.49,-8.82,;30.71,-10.15,;29.15,-10.15,;28.38,-11.5,;29.14,-12.82,;30.71,-12.82,;31.47,-11.5,;28.37,-14.17,;27.05,-13.4,;29.73,-14.94,;27.62,-15.47,;26.04,-15.47,;25.29,-14.16,;23.75,-14.12,;22.99,-15.44,;23.76,-16.79,;25.28,-16.79,;21.42,-15.44,;20.65,-16.77,;19.13,-16.77,;18.35,-15.42,;19.12,-14.09,;20.66,-14.12,;16.8,-15.42,;16.02,-16.76,;14.48,-16.76,;13.71,-15.41,;14.5,-14.09,;16.02,-14.09,;16.8,-12.75,;16.03,-11.41,;16.8,-10.08,;17.55,-8.73,;18.13,-10.84,;15.46,-9.32,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-9-11-22(12-10-21)38(34,35)32-19-5-7-20(8-6-19)33-15-13-18(14-16-33)23-3-1-2-4-24(23)36-17-26(29,30)31/h1-4,9-12,18-20,25,32H,5-8,13-17H2 GAFGMUJBSNDSHX-UHFFFAOYSA-N 50213526 4-(difluoromethoxy)-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228554 Alpha-1B adrenergic receptor Homo sapiens 302 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213526&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426405 104088875 CHEMBL228554 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387007 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:16.20,wD:13.13,(32.85,-34.59,;31.31,-34.6,;30.53,-33.27,;31.29,-31.93,;30.5,-30.6,;28.95,-30.62,;28.17,-29.3,;28.2,-31.96,;28.98,-33.28,;28.22,-34.62,;26.87,-33.89,;29.57,-35.37,;27.5,-35.99,;25.97,-36.04,;25.14,-34.74,;23.6,-34.8,;22.89,-36.16,;23.71,-37.46,;25.24,-37.4,;21.35,-36.22,;20.64,-37.58,;19.11,-37.65,;18.28,-36.35,;18.98,-34.98,;20.53,-34.92,;16.74,-36.41,;16.03,-37.78,;14.49,-37.85,;13.66,-36.54,;14.37,-35.18,;15.9,-35.11,;16.61,-33.74,;15.78,-32.44,;15.7,-30.91,;14.41,-31.74,)| InChI=1S/C27H35ClN2O4S/c1-33-26-13-6-20(28)18-27(26)35(31,32)29-21-7-9-22(10-8-21)30-16-14-19(15-17-30)24-4-2-3-5-25(24)34-23-11-12-23/h2-6,13,18-19,21-23,29H,7-12,14-17H2,1H3 CQABPCACTMBCQC-UHFFFAOYSA-N 50213514 5-chloro-N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-methoxybenzenesulfonamide::CHEMBL228279 D(2) dopamine receptor Homo sapiens 154 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213514&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857710 104088863 CHEMBL228279 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387008 O=S(=O)(N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1)c1ccc2OCOc2c1 |wU:7.10,4.3,(4.39,.82,;5.71,.06,;7.07,-.72,;4.95,-1.25,;3.38,-1.25,;2.62,-2.57,;1.1,-2.57,;.32,-1.21,;1.09,.1,;2.62,.06,;-1.24,-1.21,;-2.01,-2.54,;-3.54,-2.54,;-4.31,-1.2,;-3.54,.13,;-2.01,.1,;-5.86,-1.2,;-6.64,-2.53,;-8.18,-2.53,;-8.95,-1.18,;-8.16,.13,;-6.64,.13,;-5.86,1.48,;-6.63,2.82,;-6.63,4.36,;-7.97,3.59,;6.48,1.4,;5.71,2.72,;6.49,4.07,;8.04,4.07,;9.08,5.21,;10.49,4.57,;10.32,3.04,;8.8,2.72,;8.04,1.4,)| InChI=1S/C27H34N2O5S/c30-35(31,23-11-12-26-27(17-23)33-18-32-26)28-20-5-7-21(8-6-20)29-15-13-19(14-16-29)24-3-1-2-4-25(24)34-22-9-10-22/h1-4,11-12,17,19-22,28H,5-10,13-16,18H2 ZIIYCNPQTIYWFF-UHFFFAOYSA-N 50213517 N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzo[d][1,3]dioxole-5-sulfonamide::CHEMBL389104 D(2) dopamine receptor Homo sapiens 66 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213517&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426404 104088866 CHEMBL389104 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387009 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:15.19,wD:12.12,(31.74,-46.23,;30.97,-44.89,;31.73,-43.57,;30.98,-42.22,;29.42,-42.22,;28.65,-40.89,;28.65,-43.57,;29.41,-44.89,;28.64,-46.24,;27.32,-45.47,;30,-47.01,;27.88,-47.54,;26.31,-47.54,;25.55,-46.24,;24.01,-46.19,;23.25,-47.51,;24.03,-48.86,;25.55,-48.86,;21.68,-47.51,;20.91,-48.84,;19.39,-48.84,;18.61,-47.49,;19.38,-46.16,;20.92,-46.19,;17.06,-47.49,;16.28,-48.83,;14.74,-48.83,;13.97,-47.48,;14.76,-46.16,;16.28,-46.16,;17.06,-44.82,;16.29,-43.48,;17.06,-42.15,;17.82,-40.8,;18.39,-42.91,;15.72,-41.39,)| InChI=1S/C25H29ClF4N2O3S/c26-18-5-10-22(27)24(15-18)36(33,34)31-19-6-8-20(9-7-19)32-13-11-17(12-14-32)21-3-1-2-4-23(21)35-16-25(28,29)30/h1-5,10,15,17,19-20,31H,6-9,11-14,16H2 HNTIGZIKHBPAFD-UHFFFAOYSA-N 50213535 5-chloro-2-fluoro-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228494 Alpha-1B adrenergic receptor Homo sapiens 787 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213535&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857793 104088884 CHEMBL228494 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387010 O=S(=O)(N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1)c1ccc2OCOc2c1 |wU:7.10,wD:4.3,(26.12,.88,;27.45,.11,;28.8,-.66,;26.69,-1.19,;25.12,-1.19,;24.36,.12,;22.82,.16,;22.06,-1.16,;22.84,-2.51,;24.36,-2.51,;20.49,-1.16,;19.73,-2.49,;18.2,-2.49,;17.43,-1.14,;18.2,.19,;19.73,.16,;15.87,-1.14,;15.1,-2.48,;13.56,-2.48,;12.79,-1.13,;13.57,.19,;15.1,.19,;15.87,1.53,;15.11,2.87,;15.11,4.42,;13.77,3.64,;28.21,1.46,;27.45,2.78,;28.22,4.13,;29.78,4.13,;30.82,5.26,;32.23,4.63,;32.06,3.09,;30.54,2.78,;29.78,1.46,)| InChI=1S/C27H34N2O5S/c30-35(31,23-11-12-26-27(17-23)33-18-32-26)28-20-5-7-21(8-6-20)29-15-13-19(14-16-29)24-3-1-2-4-25(24)34-22-9-10-22/h1-4,11-12,17,19-22,28H,5-10,13-16,18H2 ZIIYCNPQTIYWFF-UHFFFAOYSA-N 50213534 N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzo[d][1,3]dioxole-5-sulfonamide::CHEMBL228333 D(2) dopamine receptor Homo sapiens 71 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213534&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426404 104088883 CHEMBL228333 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387011 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.42,6.24,;7.88,6.23,;7.12,4.89,;5.57,4.87,;4.82,3.53,;5.6,2.21,;7.14,2.22,;7.9,3.56,;9.44,3.57,;10.22,2.24,;4.84,.87,;3.49,1.6,;6.19,.12,;4.12,-.5,;2.58,-.55,;1.86,-1.91,;.33,-1.97,;-.49,-.67,;.22,.69,;1.76,.75,;-2.03,-.73,;-2.75,-2.09,;-4.28,-2.16,;-5.11,-.86,;-4.4,.51,;-2.86,.57,;-6.64,-.92,;-7.36,-2.29,;-8.9,-2.36,;-9.72,-1.05,;-9.02,.31,;-7.48,.38,;-6.78,1.75,;-7.61,3.05,;-6.9,4.41,;-9.15,2.97,)| InChI=1S/C28H40N2O5S/c1-20(2)35-26-8-6-5-7-25(26)21-15-17-30(18-16-21)23-11-9-22(10-12-23)29-36(31,32)24-13-14-27(33-3)28(19-24)34-4/h5-8,13-14,19-23,29H,9-12,15-18H2,1-4H3 ACYCBNFGNBHQEP-UHFFFAOYSA-N 50213521 N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL390129 Alpha-1A adrenergic receptor Homo sapiens 2.2 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213521&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857638 104088870 CHEMBL390129 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387012 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCCF |wU:17.21,14.14,(9.78,-22.9,;8.24,-22.89,;7.46,-24.22,;5.9,-24.22,;5.13,-25.56,;5.89,-26.89,;7.45,-26.89,;8.21,-25.57,;9.75,-25.58,;10.52,-26.91,;5.12,-28.23,;3.8,-27.47,;6.48,-29.01,;4.36,-29.54,;2.79,-29.54,;2.03,-30.86,;.51,-30.86,;-.27,-29.51,;.5,-28.19,;2.03,-28.23,;-1.84,-29.51,;-2.6,-30.83,;-4.13,-30.83,;-4.91,-29.49,;-4.14,-28.16,;-2.6,-28.19,;-6.46,-29.49,;-7.23,-30.83,;-8.77,-30.83,;-9.55,-29.48,;-8.76,-28.16,;-7.24,-28.16,;-6.46,-26.81,;-7.23,-25.48,;-6.46,-24.14,;-7.23,-22.81,)| InChI=1S/C27H37FN2O5S/c1-33-26-12-11-23(19-27(26)34-2)36(31,32)29-21-7-9-22(10-8-21)30-16-13-20(14-17-30)24-5-3-4-6-25(24)35-18-15-28/h3-6,11-12,19-22,29H,7-10,13-18H2,1-2H3 NZOIFXLLVJGITJ-UHFFFAOYSA-N 50213536 N-((1s,4s)-4-(4-(2-(2-fluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL538397 Alpha-1A adrenergic receptor Homo sapiens 8.5 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213536&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857861 104088885 CHEMBL538397 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387013 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:17.21,wD:14.14,(32.87,-18.24,;31.33,-18.26,;30.57,-19.6,;29.02,-19.61,;28.27,-20.96,;29.05,-22.28,;30.59,-22.27,;31.35,-20.93,;32.89,-20.92,;33.67,-22.24,;28.29,-23.62,;26.94,-22.88,;29.64,-24.36,;27.57,-24.98,;26.03,-25.04,;25.21,-23.74,;23.67,-23.79,;22.96,-25.16,;23.78,-26.46,;25.31,-26.4,;21.42,-25.21,;20.7,-26.58,;19.17,-26.64,;18.34,-25.34,;19.05,-23.98,;20.59,-23.91,;16.81,-25.41,;16.09,-26.78,;14.55,-26.84,;13.73,-25.54,;14.43,-24.18,;15.97,-24.1,;16.67,-22.73,;15.84,-21.44,;15.77,-19.91,;14.47,-20.74,)| InChI=1S/C28H38N2O5S/c1-33-27-14-13-24(19-28(27)34-2)36(31,32)29-21-7-9-22(10-8-21)30-17-15-20(16-18-30)25-5-3-4-6-26(25)35-23-11-12-23/h3-6,13-14,19-23,29H,7-12,15-18H2,1-2H3 JFRXSPVSGNWHOD-UHFFFAOYSA-N 50213513 N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228278 D(2) dopamine receptor Homo sapiens 133 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213513&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11519153 104088862 CHEMBL228278 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387014 FC(F)Oc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(33.81,-7.51,;33.03,-8.83,;33.79,-10.17,;31.49,-8.82,;30.71,-10.15,;29.15,-10.15,;28.38,-11.5,;29.14,-12.82,;30.71,-12.82,;31.47,-11.5,;28.37,-14.17,;27.05,-13.4,;29.73,-14.94,;27.62,-15.47,;26.04,-15.47,;25.29,-14.16,;23.75,-14.12,;22.99,-15.44,;23.76,-16.79,;25.28,-16.79,;21.42,-15.44,;20.65,-16.77,;19.13,-16.77,;18.35,-15.42,;19.12,-14.09,;20.66,-14.12,;16.8,-15.42,;16.02,-16.76,;14.48,-16.76,;13.71,-15.41,;14.5,-14.09,;16.02,-14.09,;16.8,-12.75,;16.03,-11.41,;16.8,-10.08,;17.55,-8.73,;18.13,-10.84,;15.46,-9.32,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-9-11-22(12-10-21)38(34,35)32-19-5-7-20(8-6-19)33-15-13-18(14-16-33)23-3-1-2-4-24(23)36-17-26(29,30)31/h1-4,9-12,18-20,25,32H,5-8,13-17H2 GAFGMUJBSNDSHX-UHFFFAOYSA-N 50213526 4-(difluoromethoxy)-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228554 D(2) dopamine receptor Homo sapiens 104 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213526&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426405 104088875 CHEMBL228554 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387015 CC(C)Oc1ccccc1C1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc(F)c(F)c1 |wU:16.17,19.24,(-7.13,-7.52,;-7.84,-8.89,;-9.38,-8.96,;-7.01,-10.18,;-7.71,-11.55,;-9.25,-11.62,;-9.96,-12.99,;-9.13,-14.29,;-7.59,-14.22,;-6.88,-12.85,;-5.34,-12.79,;-4.51,-14.09,;-2.98,-14.02,;-2.26,-12.66,;-3.09,-11.36,;-4.63,-11.42,;-.73,-12.6,;.09,-13.91,;1.63,-13.85,;2.35,-12.49,;1.52,-11.18,;-.02,-11.24,;3.88,-12.43,;4.6,-11.07,;3.25,-10.33,;5.95,-11.81,;5.36,-9.72,;4.58,-8.4,;5.34,-7.06,;6.89,-7.04,;7.64,-5.7,;7.67,-8.38,;9.21,-8.36,;6.91,-9.72,)| InChI=1S/C26H34F2N2O3S/c1-18(2)33-26-6-4-3-5-23(26)19-13-15-30(16-14-19)21-9-7-20(8-10-21)29-34(31,32)22-11-12-24(27)25(28)17-22/h3-6,11-12,17-21,29H,7-10,13-16H2,1-2H3 NHRXMVNDSUMAIN-UHFFFAOYSA-N 50213528 3,4-difluoro-N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL390184 Alpha-1A adrenergic receptor Homo sapiens 3 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213528&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857639 104088877 CHEMBL390184 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387016 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC(C)C |wU:17.21,wD:14.14,(30.34,5.31,;28.8,5.3,;28.05,3.95,;26.49,3.94,;25.74,2.59,;26.52,1.27,;28.07,1.28,;28.83,2.62,;30.37,2.64,;31.15,1.31,;25.76,-.07,;24.41,.67,;27.11,-.81,;25.04,-1.43,;23.51,-1.49,;22.68,-.18,;21.14,-.24,;20.43,-1.6,;21.25,-2.91,;22.79,-2.85,;18.9,-1.66,;18.18,-3.02,;16.65,-3.09,;15.82,-1.79,;16.53,-.42,;18.07,-.36,;14.28,-1.85,;13.57,-3.22,;12.03,-3.29,;11.2,-1.99,;11.91,-.62,;13.45,-.55,;14.15,.82,;13.32,2.11,;14.03,3.48,;11.78,2.04,)| InChI=1S/C28H40N2O5S/c1-20(2)35-26-8-6-5-7-25(26)21-15-17-30(18-16-21)23-11-9-22(10-12-23)29-36(31,32)24-13-14-27(33-3)28(19-24)34-4/h5-8,13-14,19-23,29H,9-12,15-18H2,1-4H3 ACYCBNFGNBHQEP-UHFFFAOYSA-N 50213524 N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL388361 Alpha-1D adrenergic receptor Homo sapiens 40 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213524&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857638 104088873 CHEMBL388361 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387017 FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(34.74,.1,;33.2,.11,;32.43,-1.22,;32.44,1.45,;30.9,1.46,;30.15,2.81,;28.59,2.81,;27.82,1.46,;28.58,.13,;30.14,.13,;27.81,-1.21,;26.49,-.44,;29.17,-1.98,;27.05,-2.51,;25.48,-2.51,;24.72,-1.21,;23.19,-1.16,;22.42,-2.48,;23.2,-3.83,;24.72,-3.83,;20.86,-2.48,;20.09,-3.81,;18.56,-3.81,;17.79,-2.46,;18.56,-1.13,;20.09,-1.16,;16.23,-2.46,;15.46,-3.8,;13.92,-3.8,;13.15,-2.45,;13.93,-1.13,;15.46,-1.13,;16.23,.21,;15.46,1.55,;16.23,2.88,;16.99,4.22,;17.57,2.12,;14.89,3.64,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2 RVPGPLCUKORXKA-UHFFFAOYSA-N 50213531 3-(difluoromethoxy)-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228553 D(2) dopamine receptor Homo sapiens 129 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213531&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857794 104088880 CHEMBL228553 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387018 FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.92,.29,;9.38,.29,;8.6,-1.03,;8.62,1.63,;7.08,1.64,;6.32,2.99,;4.76,2.99,;3.99,1.64,;4.75,.32,;6.32,.32,;3.98,-1.02,;2.66,-.26,;5.34,-1.8,;3.23,-2.33,;1.65,-2.33,;.89,-3.65,;-.63,-3.65,;-1.4,-2.3,;-.64,-.98,;.9,-1.02,;-2.97,-2.3,;-3.74,-3.62,;-5.27,-3.62,;-6.04,-2.28,;-5.27,-.95,;-3.73,-.98,;-7.59,-2.28,;-8.37,-3.62,;-9.91,-3.62,;-10.68,-2.27,;-9.89,-.95,;-8.37,-.95,;-7.59,.4,;-8.37,1.73,;-7.6,3.07,;-6.84,4.41,;-6.26,2.3,;-8.94,3.83,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2 RVPGPLCUKORXKA-UHFFFAOYSA-N 50213520 3-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228496 Alpha-1B adrenergic receptor Homo sapiens 261 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213520&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857794 104088869 CHEMBL228496 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387019 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(31.88,-7.8,;30.34,-7.79,;29.56,-9.12,;28,-9.12,;27.23,-10.47,;27.99,-11.79,;29.55,-11.79,;30.32,-10.47,;31.86,-10.48,;32.62,-11.82,;27.22,-13.13,;25.9,-12.37,;28.58,-13.91,;26.47,-14.44,;24.89,-14.44,;24.14,-13.13,;22.6,-13.09,;21.84,-14.41,;22.61,-15.76,;24.13,-15.76,;20.27,-14.41,;19.5,-15.73,;17.98,-15.73,;17.2,-14.39,;17.97,-13.06,;19.51,-13.09,;15.65,-14.39,;14.87,-15.72,;13.33,-15.72,;12.56,-14.38,;13.35,-13.06,;14.87,-13.06,;15.65,-11.71,;14.88,-10.38,;15.64,-9.04,;16.4,-7.7,;16.98,-9.81,;14.31,-8.28,)| InChI=1S/C27H35F3N2O5S/c1-35-25-12-11-22(17-26(25)36-2)38(33,34)31-20-7-9-21(10-8-20)32-15-13-19(14-16-32)23-5-3-4-6-24(23)37-18-27(28,29)30/h3-6,11-12,17,19-21,31H,7-10,13-16,18H2,1-2H3 USIWFTPEBGPOSA-UHFFFAOYSA-N 50213537 3,4-dimethoxy-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228389 Alpha-1B adrenergic receptor Homo sapiens 368 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213537&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857709 104088886 CHEMBL228389 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387020 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:17.21,14.14,(10.4,-18.11,;8.86,-18.12,;8.11,-19.46,;6.55,-19.48,;5.8,-20.82,;6.58,-22.14,;8.13,-22.14,;8.89,-20.8,;10.43,-20.78,;11.21,-22.11,;5.82,-23.49,;4.47,-22.75,;7.17,-24.23,;5.1,-24.85,;3.57,-24.91,;2.85,-26.27,;1.31,-26.33,;.49,-25.02,;1.2,-23.66,;2.75,-23.6,;-1.04,-25.08,;-1.76,-26.44,;-3.29,-26.51,;-4.12,-25.21,;-3.41,-23.84,;-1.87,-23.78,;-5.66,-25.27,;-6.37,-26.64,;-7.91,-26.71,;-8.73,-25.41,;-8.03,-24.04,;-6.49,-23.97,;-5.79,-22.6,;-6.62,-21.31,;-6.69,-19.77,;-7.99,-20.6,)| InChI=1S/C28H38N2O5S/c1-33-27-14-13-24(19-28(27)34-2)36(31,32)29-21-7-9-22(10-8-21)30-17-15-20(16-18-30)25-5-3-4-6-26(25)35-23-11-12-23/h3-6,13-14,19-23,29H,7-12,15-18H2,1-2H3 JFRXSPVSGNWHOD-UHFFFAOYSA-N 50213511 N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL229085 Alpha-1B adrenergic receptor Homo sapiens 141 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213511&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11519153 104088860 CHEMBL229085 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387021 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:16.20,wD:13.13,(33.93,-35.76,;32.39,-35.76,;31.62,-34.43,;32.38,-33.1,;31.63,-31.76,;30.07,-31.76,;29.3,-30.42,;29.3,-33.1,;30.06,-34.43,;29.29,-35.77,;27.97,-35.01,;30.65,-36.55,;28.53,-37.08,;26.96,-37.08,;26.2,-35.77,;24.67,-35.73,;23.9,-37.04,;24.68,-38.4,;26.2,-38.4,;22.33,-37.04,;21.57,-38.37,;20.04,-38.37,;19.26,-37.03,;20.03,-35.69,;21.57,-35.73,;17.71,-37.03,;16.94,-38.36,;15.4,-38.36,;14.62,-37.01,;15.41,-35.69,;16.93,-35.69,;17.71,-34.35,;16.94,-33.02,;17.71,-31.68,;18.47,-30.34,;19.05,-32.44,;16.37,-30.92,)| InChI=1S/C26H32ClF3N2O4S/c1-35-24-11-6-19(27)16-25(24)37(33,34)31-20-7-9-21(10-8-20)32-14-12-18(13-15-32)22-4-2-3-5-23(22)36-17-26(28,29)30/h2-6,11,16,18,20-21,31H,7-10,12-15,17H2,1H3 WDZOSSNSOBKEMP-UHFFFAOYSA-N 50213515 5-chloro-2-methoxy-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL390192 Alpha-1D adrenergic receptor Homo sapiens 36 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213515&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857792 104088864 CHEMBL390192 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387022 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:16.20,13.13,(10.72,-35.85,;9.18,-35.85,;8.41,-34.51,;9.17,-33.19,;8.41,-31.84,;6.86,-31.84,;6.08,-30.51,;6.08,-33.19,;6.85,-34.51,;6.08,-35.86,;4.75,-35.09,;7.44,-36.63,;5.32,-37.16,;3.75,-37.16,;2.99,-38.48,;1.47,-38.48,;.69,-37.13,;1.45,-35.81,;2.99,-35.86,;-.88,-37.13,;-1.65,-38.46,;-3.17,-38.46,;-3.95,-37.11,;-3.18,-35.78,;-1.64,-35.81,;-5.5,-37.11,;-6.28,-38.45,;-7.82,-38.45,;-8.59,-37.1,;-7.8,-35.78,;-6.28,-35.78,;-5.5,-34.44,;-6.27,-33.1,;-5.5,-31.77,;-4.75,-30.43,;-4.17,-32.53,;-6.84,-31.01,)| InChI=1S/C26H32ClF3N2O4S/c1-35-24-11-6-19(27)16-25(24)37(33,34)31-20-7-9-21(10-8-20)32-14-12-18(13-15-32)22-4-2-3-5-23(22)36-17-26(28,29)30/h2-6,11,16,18,20-21,31H,7-10,12-15,17H2,1H3 WDZOSSNSOBKEMP-UHFFFAOYSA-N 50213522 5-chloro-2-methoxy-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL442059 Alpha-1D adrenergic receptor Homo sapiens 1.6 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213522&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857792 104088871 CHEMBL442059 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387023 CC(C)Oc1ccccc1C1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc(F)c(F)c1 |wU:16.17,19.24,(-7.13,-7.52,;-7.84,-8.89,;-9.38,-8.96,;-7.01,-10.18,;-7.71,-11.55,;-9.25,-11.62,;-9.96,-12.99,;-9.13,-14.29,;-7.59,-14.22,;-6.88,-12.85,;-5.34,-12.79,;-4.51,-14.09,;-2.98,-14.02,;-2.26,-12.66,;-3.09,-11.36,;-4.63,-11.42,;-.73,-12.6,;.09,-13.91,;1.63,-13.85,;2.35,-12.49,;1.52,-11.18,;-.02,-11.24,;3.88,-12.43,;4.6,-11.07,;3.25,-10.33,;5.95,-11.81,;5.36,-9.72,;4.58,-8.4,;5.34,-7.06,;6.89,-7.04,;7.64,-5.7,;7.67,-8.38,;9.21,-8.36,;6.91,-9.72,)| InChI=1S/C26H34F2N2O3S/c1-18(2)33-26-6-4-3-5-23(26)19-13-15-30(16-14-19)21-9-7-20(8-10-21)29-34(31,32)22-11-12-24(27)25(28)17-22/h3-6,11-12,17-21,29H,7-10,13-16H2,1-2H3 NHRXMVNDSUMAIN-UHFFFAOYSA-N 50213528 3,4-difluoro-N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL390184 Alpha-1D adrenergic receptor Homo sapiens 7.3 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213528&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857639 104088877 CHEMBL390184 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387024 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.65,-7.4,;9.11,-7.39,;8.33,-8.72,;6.77,-8.72,;6,-10.07,;6.76,-11.39,;8.32,-11.39,;9.08,-10.07,;10.62,-10.08,;11.38,-11.42,;5.99,-12.74,;4.67,-11.97,;7.35,-13.51,;5.23,-14.04,;3.66,-14.04,;2.9,-15.36,;1.38,-15.36,;.6,-14.01,;1.37,-12.69,;2.9,-12.73,;-.96,-14.01,;-1.73,-15.34,;-3.26,-15.34,;-4.03,-13.99,;-3.26,-12.66,;-1.73,-12.69,;-5.59,-13.99,;-6.36,-15.33,;-7.9,-15.33,;-8.67,-13.98,;-7.89,-12.66,;-6.36,-12.66,;-5.59,-11.31,;-6.36,-9.98,;-5.59,-8.65,;-4.83,-7.3,;-4.25,-9.41,;-6.93,-7.89,)| InChI=1S/C27H35F3N2O5S/c1-35-25-12-11-22(17-26(25)36-2)38(33,34)31-20-7-9-21(10-8-20)32-15-13-19(14-16-32)23-5-3-4-6-24(23)37-18-27(28,29)30/h3-6,11-12,17,19-21,31H,7-10,13-16,18H2,1-2H3 USIWFTPEBGPOSA-UHFFFAOYSA-N 50213525 3,4-dimethoxy-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228334 Alpha-1B adrenergic receptor Homo sapiens 123 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213525&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857709 104088874 CHEMBL228334 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387025 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC(C)C |wU:17.21,wD:14.14,(30.34,5.31,;28.8,5.3,;28.05,3.95,;26.49,3.94,;25.74,2.59,;26.52,1.27,;28.07,1.28,;28.83,2.62,;30.37,2.64,;31.15,1.31,;25.76,-.07,;24.41,.67,;27.11,-.81,;25.04,-1.43,;23.51,-1.49,;22.68,-.18,;21.14,-.24,;20.43,-1.6,;21.25,-2.91,;22.79,-2.85,;18.9,-1.66,;18.18,-3.02,;16.65,-3.09,;15.82,-1.79,;16.53,-.42,;18.07,-.36,;14.28,-1.85,;13.57,-3.22,;12.03,-3.29,;11.2,-1.99,;11.91,-.62,;13.45,-.55,;14.15,.82,;13.32,2.11,;14.03,3.48,;11.78,2.04,)| InChI=1S/C28H40N2O5S/c1-20(2)35-26-8-6-5-7-25(26)21-15-17-30(18-16-21)23-11-9-22(10-12-23)29-36(31,32)24-13-14-27(33-3)28(19-24)34-4/h5-8,13-14,19-23,29H,9-12,15-18H2,1-4H3 ACYCBNFGNBHQEP-UHFFFAOYSA-N 50213524 N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL388361 Alpha-1B adrenergic receptor Homo sapiens 148 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213524&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857638 104088873 CHEMBL388361 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387026 FC(F)Oc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.76,-7.54,;9.98,-8.87,;10.75,-10.21,;8.44,-8.86,;7.67,-10.19,;6.11,-10.19,;5.34,-11.54,;6.1,-12.86,;7.66,-12.86,;8.42,-11.54,;5.33,-14.21,;4.01,-13.44,;6.69,-14.98,;4.57,-15.51,;3,-15.51,;2.24,-16.83,;.72,-16.83,;-.06,-15.48,;.71,-14.16,;2.24,-14.2,;-1.62,-15.48,;-2.39,-16.81,;-3.92,-16.81,;-4.69,-15.46,;-3.92,-14.13,;-2.39,-14.16,;-6.25,-15.46,;-7.02,-16.8,;-8.56,-16.8,;-9.33,-15.45,;-8.55,-14.13,;-7.02,-14.13,;-6.25,-12.78,;-7.02,-11.45,;-6.25,-10.12,;-5.49,-8.77,;-4.91,-10.88,;-7.59,-9.36,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-9-11-22(12-10-21)38(34,35)32-19-5-7-20(8-6-19)33-15-13-18(14-16-33)23-3-1-2-4-24(23)36-17-26(29,30)31/h1-4,9-12,18-20,25,32H,5-8,13-17H2 GAFGMUJBSNDSHX-UHFFFAOYSA-N 50213509 4-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL387832 D(2) dopamine receptor Homo sapiens 154 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213509&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426405 104088858 CHEMBL387832 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387027 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:15.19,wD:12.12,(31.96,-44.68,;31.18,-43.35,;31.94,-42.01,;31.16,-40.68,;29.61,-40.69,;28.82,-39.37,;28.85,-42.04,;29.64,-43.36,;28.88,-44.7,;27.52,-43.96,;30.22,-45.44,;28.16,-46.06,;26.62,-46.12,;25.8,-44.81,;24.25,-44.87,;23.54,-46.24,;24.37,-47.54,;25.9,-47.48,;22.01,-46.29,;21.29,-47.66,;19.76,-47.72,;18.93,-46.42,;19.64,-45.05,;21.18,-44.99,;17.39,-46.49,;16.68,-47.85,;15.14,-47.92,;14.31,-46.62,;15.02,-45.26,;16.56,-45.18,;17.26,-43.81,;16.43,-42.52,;16.36,-40.99,;15.06,-41.82,)| InChI=1S/C26H32ClFN2O3S/c27-19-5-12-24(28)26(17-19)34(31,32)29-20-6-8-21(9-7-20)30-15-13-18(14-16-30)23-3-1-2-4-25(23)33-22-10-11-22/h1-5,12,17-18,20-22,29H,6-11,13-16H2 LVDRNYWTLKUNNT-UHFFFAOYSA-N 50213510 5-chloro-N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-fluorobenzenesulfonamide::CHEMBL228332 D(2) dopamine receptor Homo sapiens 159 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213510&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857711 104088859 CHEMBL228332 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387028 FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(34.74,.1,;33.2,.11,;32.43,-1.22,;32.44,1.45,;30.9,1.46,;30.15,2.81,;28.59,2.81,;27.82,1.46,;28.58,.13,;30.14,.13,;27.81,-1.21,;26.49,-.44,;29.17,-1.98,;27.05,-2.51,;25.48,-2.51,;24.72,-1.21,;23.19,-1.16,;22.42,-2.48,;23.2,-3.83,;24.72,-3.83,;20.86,-2.48,;20.09,-3.81,;18.56,-3.81,;17.79,-2.46,;18.56,-1.13,;20.09,-1.16,;16.23,-2.46,;15.46,-3.8,;13.92,-3.8,;13.15,-2.45,;13.93,-1.13,;15.46,-1.13,;16.23,.21,;15.46,1.55,;16.23,2.88,;16.99,4.22,;17.57,2.12,;14.89,3.64,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2 RVPGPLCUKORXKA-UHFFFAOYSA-N 50213531 3-(difluoromethoxy)-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228553 Alpha-1B adrenergic receptor Homo sapiens 355 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213531&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857794 104088880 CHEMBL228553 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387029 FC(F)(F)COc1ccccc1C1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc2OCCOc2c1 |wU:18.19,21.26,(-5.05,-19.16,;-5.81,-20.51,;-4.47,-21.27,;-7.15,-19.75,;-6.58,-21.84,;-5.8,-23.18,;-6.58,-24.52,;-8.1,-24.52,;-8.89,-25.84,;-8.12,-27.19,;-6.58,-27.19,;-5.8,-25.85,;-4.25,-25.85,;-3.48,-27.2,;-1.95,-27.2,;-1.18,-25.87,;-1.94,-24.55,;-3.48,-24.52,;.39,-25.87,;1.16,-27.22,;2.68,-27.22,;3.44,-25.9,;2.68,-24.59,;1.15,-24.55,;5.02,-25.9,;5.77,-24.6,;4.45,-23.83,;7.13,-25.37,;6.54,-23.25,;5.78,-21.93,;6.55,-20.58,;8.11,-20.58,;8.89,-19.25,;10.43,-19.26,;11.19,-20.6,;10.41,-21.93,;8.86,-21.93,;8.1,-23.25,)| InChI=1S/C27H33F3N2O5S/c28-27(29,30)18-37-24-4-2-1-3-23(24)19-11-13-32(14-12-19)21-7-5-20(6-8-21)31-38(33,34)22-9-10-25-26(17-22)36-16-15-35-25/h1-4,9-10,17,19-21,31H,5-8,11-16,18H2 PPAIEDLGYFCKEB-UHFFFAOYSA-N 50213516 N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide::CHEMBL439197 Alpha-1B adrenergic receptor Homo sapiens 92 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213516&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857791 104088865 CHEMBL439197 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387030 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:17.21,wD:14.14,(32.87,-18.24,;31.33,-18.26,;30.57,-19.6,;29.02,-19.61,;28.27,-20.96,;29.05,-22.28,;30.59,-22.27,;31.35,-20.93,;32.89,-20.92,;33.67,-22.24,;28.29,-23.62,;26.94,-22.88,;29.64,-24.36,;27.57,-24.98,;26.03,-25.04,;25.21,-23.74,;23.67,-23.79,;22.96,-25.16,;23.78,-26.46,;25.31,-26.4,;21.42,-25.21,;20.7,-26.58,;19.17,-26.64,;18.34,-25.34,;19.05,-23.98,;20.59,-23.91,;16.81,-25.41,;16.09,-26.78,;14.55,-26.84,;13.73,-25.54,;14.43,-24.18,;15.97,-24.1,;16.67,-22.73,;15.84,-21.44,;15.77,-19.91,;14.47,-20.74,)| InChI=1S/C28H38N2O5S/c1-33-27-14-13-24(19-28(27)34-2)36(31,32)29-21-7-9-22(10-8-21)30-17-15-20(16-18-30)25-5-3-4-6-26(25)35-23-11-12-23/h3-6,13-14,19-23,29H,7-12,15-18H2,1-2H3 JFRXSPVSGNWHOD-UHFFFAOYSA-N 50213513 N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228278 Alpha-1D adrenergic receptor Homo sapiens 34 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213513&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11519153 104088862 CHEMBL228278 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387031 FC(F)(F)COc1ccccc1C1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc2OCCOc2c1 |wU:18.19,21.26,(-5.05,-19.16,;-5.81,-20.51,;-4.47,-21.27,;-7.15,-19.75,;-6.58,-21.84,;-5.8,-23.18,;-6.58,-24.52,;-8.1,-24.52,;-8.89,-25.84,;-8.12,-27.19,;-6.58,-27.19,;-5.8,-25.85,;-4.25,-25.85,;-3.48,-27.2,;-1.95,-27.2,;-1.18,-25.87,;-1.94,-24.55,;-3.48,-24.52,;.39,-25.87,;1.16,-27.22,;2.68,-27.22,;3.44,-25.9,;2.68,-24.59,;1.15,-24.55,;5.02,-25.9,;5.77,-24.6,;4.45,-23.83,;7.13,-25.37,;6.54,-23.25,;5.78,-21.93,;6.55,-20.58,;8.11,-20.58,;8.89,-19.25,;10.43,-19.26,;11.19,-20.6,;10.41,-21.93,;8.86,-21.93,;8.1,-23.25,)| InChI=1S/C27H33F3N2O5S/c28-27(29,30)18-37-24-4-2-1-3-23(24)19-11-13-32(14-12-19)21-7-5-20(6-8-21)31-38(33,34)22-9-10-25-26(17-22)36-16-15-35-25/h1-4,9-10,17,19-21,31H,5-8,11-16,18H2 PPAIEDLGYFCKEB-UHFFFAOYSA-N 50213516 N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide::CHEMBL439197 D(2) dopamine receptor Homo sapiens 57 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213516&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857791 104088865 CHEMBL439197 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387032 CCOc1ccccc1OCCN[C@H](C)Cc2ccc(c(c2)S(=O)(=O)N)OC InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24) DRHKJLXJIQTDTD-UHFFFAOYSA-N 50060964 5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide::(R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide::5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide::CHEMBL836::TAMSULOSIN Alpha-1A adrenergic receptor Homo sapiens 0.19 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060964 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060964&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search JGX 7YMJ,8XLR 129211 103956570 CHEMBL836 DB00706 C07124 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387033 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:16.20,13.13,(10.04,-34.29,;8.5,-34.3,;7.72,-32.97,;8.48,-31.63,;7.7,-30.3,;6.15,-30.32,;5.37,-29,;5.4,-31.66,;6.18,-32.98,;5.42,-34.32,;4.07,-33.59,;6.77,-35.07,;4.7,-35.69,;3.16,-35.74,;2.44,-37.1,;.91,-37.16,;.09,-35.86,;.8,-34.5,;2.34,-34.44,;-1.45,-35.92,;-2.16,-37.28,;-3.7,-37.35,;-4.52,-36.05,;-3.82,-34.68,;-2.28,-34.62,;-6.06,-36.11,;-6.77,-37.48,;-8.31,-37.55,;-9.14,-36.24,;-8.43,-34.88,;-6.9,-34.81,;-6.19,-33.44,;-7.02,-32.14,;-7.1,-30.6,;-8.39,-31.43,)| InChI=1S/C27H35ClN2O4S/c1-33-26-13-6-20(28)18-27(26)35(31,32)29-21-7-9-22(10-8-21)30-16-14-19(15-17-30)24-4-2-3-5-25(24)34-23-11-12-23/h2-6,13,18-19,21-23,29H,7-12,14-17H2,1H3 CQABPCACTMBCQC-UHFFFAOYSA-N 50213512 5-chloro-N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-methoxybenzenesulfonamide::CHEMBL388897 Alpha-1B adrenergic receptor Homo sapiens 82 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213512&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857710 104088861 CHEMBL388897 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387034 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)F |wU:17.21,wD:14.14,(32.79,-36.92,;31.25,-36.91,;30.47,-38.24,;28.91,-38.24,;28.14,-39.59,;28.9,-40.91,;30.46,-40.91,;31.23,-39.59,;32.77,-39.6,;33.53,-40.94,;28.13,-42.25,;26.81,-41.49,;29.49,-43.03,;27.38,-43.56,;25.8,-43.56,;25.04,-42.25,;23.51,-42.21,;22.75,-43.53,;23.52,-44.88,;25.04,-44.88,;21.18,-43.53,;20.41,-44.86,;18.88,-44.86,;18.11,-43.51,;18.88,-42.18,;20.41,-42.21,;16.55,-43.51,;15.78,-44.85,;14.24,-44.85,;13.47,-43.5,;14.25,-42.18,;15.78,-42.18,;16.55,-40.83,;15.78,-39.5,;16.55,-38.16,;15.78,-36.83,;18.09,-38.16,)| InChI=1S/C27H36F2N2O5S/c1-34-25-12-11-22(17-26(25)35-2)37(32,33)30-20-7-9-21(10-8-20)31-15-13-19(14-16-31)23-5-3-4-6-24(23)36-18-27(28)29/h3-6,11-12,17,19-21,27,30H,7-10,13-16,18H2,1-2H3 QLLKZBYEHJGRHK-UHFFFAOYSA-N 50213533 N-((1r,4r)-4-(4-(2-(2,2-difluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228607 D(2) dopamine receptor Homo sapiens 88 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213533&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857862 104088882 CHEMBL228607 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387035 FC(F)Oc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(33.81,-7.51,;33.03,-8.83,;33.79,-10.17,;31.49,-8.82,;30.71,-10.15,;29.15,-10.15,;28.38,-11.5,;29.14,-12.82,;30.71,-12.82,;31.47,-11.5,;28.37,-14.17,;27.05,-13.4,;29.73,-14.94,;27.62,-15.47,;26.04,-15.47,;25.29,-14.16,;23.75,-14.12,;22.99,-15.44,;23.76,-16.79,;25.28,-16.79,;21.42,-15.44,;20.65,-16.77,;19.13,-16.77,;18.35,-15.42,;19.12,-14.09,;20.66,-14.12,;16.8,-15.42,;16.02,-16.76,;14.48,-16.76,;13.71,-15.41,;14.5,-14.09,;16.02,-14.09,;16.8,-12.75,;16.03,-11.41,;16.8,-10.08,;17.55,-8.73,;18.13,-10.84,;15.46,-9.32,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-9-11-22(12-10-21)38(34,35)32-19-5-7-20(8-6-19)33-15-13-18(14-16-33)23-3-1-2-4-24(23)36-17-26(29,30)31/h1-4,9-12,18-20,25,32H,5-8,13-17H2 GAFGMUJBSNDSHX-UHFFFAOYSA-N 50213526 4-(difluoromethoxy)-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228554 Alpha-1A adrenergic receptor Homo sapiens 38 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213526&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426405 104088875 CHEMBL228554 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387036 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:15.19,12.12,(9.95,-45.7,;9.18,-44.37,;9.94,-43.03,;9.15,-41.7,;7.6,-41.72,;6.82,-40.4,;6.85,-43.06,;7.63,-44.38,;6.87,-45.72,;5.52,-44.99,;8.22,-46.47,;6.15,-47.08,;4.62,-47.14,;3.89,-48.5,;2.36,-48.56,;1.54,-47.26,;2.25,-45.9,;3.79,-45.84,;.01,-47.32,;-.71,-48.68,;-2.24,-48.74,;-3.07,-47.44,;-2.36,-46.08,;-.82,-46.02,;-4.61,-47.51,;-5.32,-48.88,;-6.86,-48.95,;-7.68,-47.64,;-6.98,-46.28,;-5.44,-46.21,;-4.74,-44.84,;-5.57,-43.54,;-5.64,-42,;-6.94,-42.83,)| InChI=1S/C26H32ClFN2O3S/c27-19-5-12-24(28)26(17-19)34(31,32)29-20-6-8-21(9-7-20)30-15-13-18(14-16-30)23-3-1-2-4-25(23)33-22-10-11-22/h1-5,12,17-18,20-22,29H,6-11,13-16H2 LVDRNYWTLKUNNT-UHFFFAOYSA-N 50213538 5-chloro-N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-fluorobenzenesulfonamide::CHEMBL228280 Alpha-1A adrenergic receptor Homo sapiens 1.8 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213538&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857711 104088887 CHEMBL228280 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387037 O=S(=O)(N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1)c1ccc2OCOc2c1 |wU:7.10,wD:4.3,(26.12,.88,;27.45,.11,;28.8,-.66,;26.69,-1.19,;25.12,-1.19,;24.36,.12,;22.82,.16,;22.06,-1.16,;22.84,-2.51,;24.36,-2.51,;20.49,-1.16,;19.73,-2.49,;18.2,-2.49,;17.43,-1.14,;18.2,.19,;19.73,.16,;15.87,-1.14,;15.1,-2.48,;13.56,-2.48,;12.79,-1.13,;13.57,.19,;15.1,.19,;15.87,1.53,;15.11,2.87,;15.11,4.42,;13.77,3.64,;28.21,1.46,;27.45,2.78,;28.22,4.13,;29.78,4.13,;30.82,5.26,;32.23,4.63,;32.06,3.09,;30.54,2.78,;29.78,1.46,)| InChI=1S/C27H34N2O5S/c30-35(31,23-11-12-26-27(17-23)33-18-32-26)28-20-5-7-21(8-6-20)29-15-13-19(14-16-29)24-3-1-2-4-25(24)34-22-9-10-22/h1-4,11-12,17,19-22,28H,5-10,13-16,18H2 ZIIYCNPQTIYWFF-UHFFFAOYSA-N 50213534 N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzo[d][1,3]dioxole-5-sulfonamide::CHEMBL228333 Alpha-1D adrenergic receptor Homo sapiens 57 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213534&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426404 104088883 CHEMBL228333 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387038 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:16.20,13.13,(10.72,-35.85,;9.18,-35.85,;8.41,-34.51,;9.17,-33.19,;8.41,-31.84,;6.86,-31.84,;6.08,-30.51,;6.08,-33.19,;6.85,-34.51,;6.08,-35.86,;4.75,-35.09,;7.44,-36.63,;5.32,-37.16,;3.75,-37.16,;2.99,-38.48,;1.47,-38.48,;.69,-37.13,;1.45,-35.81,;2.99,-35.86,;-.88,-37.13,;-1.65,-38.46,;-3.17,-38.46,;-3.95,-37.11,;-3.18,-35.78,;-1.64,-35.81,;-5.5,-37.11,;-6.28,-38.45,;-7.82,-38.45,;-8.59,-37.1,;-7.8,-35.78,;-6.28,-35.78,;-5.5,-34.44,;-6.27,-33.1,;-5.5,-31.77,;-4.75,-30.43,;-4.17,-32.53,;-6.84,-31.01,)| InChI=1S/C26H32ClF3N2O4S/c1-35-24-11-6-19(27)16-25(24)37(33,34)31-20-7-9-21(10-8-20)32-14-12-18(13-15-32)22-4-2-3-5-23(22)36-17-26(28,29)30/h2-6,11,16,18,20-21,31H,7-10,12-15,17H2,1H3 WDZOSSNSOBKEMP-UHFFFAOYSA-N 50213522 5-chloro-2-methoxy-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL442059 Alpha-1B adrenergic receptor Homo sapiens 216 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213522&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857792 104088871 CHEMBL442059 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387039 CCOc1ccccc1OCCN[C@H](C)Cc2ccc(c(c2)S(=O)(=O)N)OC InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24) DRHKJLXJIQTDTD-UHFFFAOYSA-N 50060964 5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide::(R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide::5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide::CHEMBL836::TAMSULOSIN Alpha-1B adrenergic receptor Homo sapiens 2 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060964 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060964&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search JGX 129211 103956570 CHEMBL836 DB00706 C07124 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387040 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccc(F)cc1OC(C)C |wU:17.21,14.14,(10.4,4.9,;8.86,4.91,;8.09,3.58,;6.53,3.58,;5.76,2.24,;6.52,.91,;8.08,.91,;8.84,2.23,;10.38,2.22,;11.14,.89,;5.75,-.43,;4.43,.33,;7.11,-1.21,;4.99,-1.74,;3.42,-1.74,;2.66,-3.06,;1.14,-3.06,;.36,-1.71,;1.13,-.39,;2.66,-.43,;-1.2,-1.71,;-1.97,-3.03,;-3.5,-3.03,;-4.27,-1.69,;-3.5,-.36,;-1.97,-.39,;-5.83,-1.69,;-6.6,-3.02,;-8.14,-3.02,;-8.91,-1.68,;-10.45,-1.66,;-8.13,-.36,;-6.6,-.36,;-5.83,.99,;-6.6,2.32,;-5.83,3.66,;-8.14,2.32,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-27-17-21(29)5-11-25(27)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-26(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 FEQSGCAJKJDTEE-UHFFFAOYSA-N 50213532 N-((1s,4s)-4-(4-(4-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228608 Alpha-1B adrenergic receptor Homo sapiens 690 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213532&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857863 104088881 CHEMBL228608 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387041 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCCF |wU:17.21,wD:14.14,(31.66,-22.48,;30.12,-22.47,;29.34,-23.8,;27.78,-23.8,;27.01,-25.15,;27.77,-26.47,;29.33,-26.47,;30.09,-25.15,;31.63,-25.16,;32.4,-26.5,;27,-27.82,;25.68,-27.05,;28.36,-28.59,;26.24,-29.13,;24.67,-29.13,;23.91,-27.82,;22.38,-27.77,;21.61,-29.09,;22.39,-30.44,;23.91,-30.44,;20.04,-29.09,;19.28,-30.42,;17.75,-30.42,;16.97,-29.08,;17.74,-27.74,;19.28,-27.77,;15.42,-29.08,;14.64,-30.41,;13.1,-30.41,;12.33,-29.06,;13.12,-27.74,;14.64,-27.74,;15.42,-26.4,;14.65,-25.06,;15.42,-23.73,;14.65,-22.4,)| InChI=1S/C27H37FN2O5S/c1-33-26-12-11-23(19-27(26)34-2)36(31,32)29-21-7-9-22(10-8-21)30-16-13-20(14-17-30)24-5-3-4-6-25(24)35-18-15-28/h3-6,11-12,19-22,29H,7-10,13-18H2,1-2H3 NZOIFXLLVJGITJ-UHFFFAOYSA-N 50213519 N-((1r,4r)-4-(4-(2-(2-fluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228606 Alpha-1D adrenergic receptor Homo sapiens 49 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213519&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857861 104088868 CHEMBL228606 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387042 FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.92,.29,;9.38,.29,;8.6,-1.03,;8.62,1.63,;7.08,1.64,;6.32,2.99,;4.76,2.99,;3.99,1.64,;4.75,.32,;6.32,.32,;3.98,-1.02,;2.66,-.26,;5.34,-1.8,;3.23,-2.33,;1.65,-2.33,;.89,-3.65,;-.63,-3.65,;-1.4,-2.3,;-.64,-.98,;.9,-1.02,;-2.97,-2.3,;-3.74,-3.62,;-5.27,-3.62,;-6.04,-2.28,;-5.27,-.95,;-3.73,-.98,;-7.59,-2.28,;-8.37,-3.62,;-9.91,-3.62,;-10.68,-2.27,;-9.89,-.95,;-8.37,-.95,;-7.59,.4,;-8.37,1.73,;-7.6,3.07,;-6.84,4.41,;-6.26,2.3,;-8.94,3.83,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2 RVPGPLCUKORXKA-UHFFFAOYSA-N 50213520 3-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228496 D(2) dopamine receptor Homo sapiens 85 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213520&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857794 104088869 CHEMBL228496 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387043 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)F |wU:17.21,wD:14.14,(32.79,-36.92,;31.25,-36.91,;30.47,-38.24,;28.91,-38.24,;28.14,-39.59,;28.9,-40.91,;30.46,-40.91,;31.23,-39.59,;32.77,-39.6,;33.53,-40.94,;28.13,-42.25,;26.81,-41.49,;29.49,-43.03,;27.38,-43.56,;25.8,-43.56,;25.04,-42.25,;23.51,-42.21,;22.75,-43.53,;23.52,-44.88,;25.04,-44.88,;21.18,-43.53,;20.41,-44.86,;18.88,-44.86,;18.11,-43.51,;18.88,-42.18,;20.41,-42.21,;16.55,-43.51,;15.78,-44.85,;14.24,-44.85,;13.47,-43.5,;14.25,-42.18,;15.78,-42.18,;16.55,-40.83,;15.78,-39.5,;16.55,-38.16,;15.78,-36.83,;18.09,-38.16,)| InChI=1S/C27H36F2N2O5S/c1-34-25-12-11-22(17-26(25)35-2)37(32,33)30-20-7-9-21(10-8-20)31-15-13-19(14-16-31)23-5-3-4-6-24(23)36-18-27(28)29/h3-6,11-12,17,19-21,27,30H,7-10,13-16,18H2,1-2H3 QLLKZBYEHJGRHK-UHFFFAOYSA-N 50213533 N-((1r,4r)-4-(4-(2-(2,2-difluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228607 Alpha-1A adrenergic receptor Homo sapiens 31 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213533&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857862 104088882 CHEMBL228607 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387044 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1cc(F)ccc1OC(C)C |wU:17.21,14.14,(10.23,-7.86,;8.69,-7.85,;7.91,-9.18,;6.36,-9.18,;5.59,-10.53,;6.35,-11.85,;7.91,-11.85,;8.67,-10.53,;10.21,-10.54,;10.97,-11.88,;5.58,-13.19,;4.26,-12.43,;6.94,-13.97,;4.82,-14.5,;3.25,-14.5,;2.49,-15.82,;.97,-15.82,;.19,-14.47,;.96,-13.15,;2.49,-13.19,;-1.38,-14.47,;-2.14,-15.8,;-3.67,-15.8,;-4.45,-14.45,;-3.67,-13.12,;-2.14,-13.15,;-6,-14.45,;-6.77,-15.79,;-8.31,-15.79,;-9.08,-17.12,;-9.08,-14.44,;-8.3,-13.12,;-6.77,-13.12,;-6,-11.77,;-6.77,-10.44,;-6,-9.11,;-8.31,-10.44,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-26-11-5-21(29)17-25(26)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-27(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 AEJCTJSNUNXYQL-UHFFFAOYSA-N 50213530 N-((1s,4s)-4-(4-(5-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228659 D(2) dopamine receptor Homo sapiens 178 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213530&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857864 104088879 CHEMBL228659 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387045 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(31.88,-7.8,;30.34,-7.79,;29.56,-9.12,;28,-9.12,;27.23,-10.47,;27.99,-11.79,;29.55,-11.79,;30.32,-10.47,;31.86,-10.48,;32.62,-11.82,;27.22,-13.13,;25.9,-12.37,;28.58,-13.91,;26.47,-14.44,;24.89,-14.44,;24.14,-13.13,;22.6,-13.09,;21.84,-14.41,;22.61,-15.76,;24.13,-15.76,;20.27,-14.41,;19.5,-15.73,;17.98,-15.73,;17.2,-14.39,;17.97,-13.06,;19.51,-13.09,;15.65,-14.39,;14.87,-15.72,;13.33,-15.72,;12.56,-14.38,;13.35,-13.06,;14.87,-13.06,;15.65,-11.71,;14.88,-10.38,;15.64,-9.04,;16.4,-7.7,;16.98,-9.81,;14.31,-8.28,)| InChI=1S/C27H35F3N2O5S/c1-35-25-12-11-22(17-26(25)36-2)38(33,34)31-20-7-9-21(10-8-20)32-15-13-19(14-16-32)23-5-3-4-6-24(23)37-18-27(28,29)30/h3-6,11-12,17,19-21,31H,7-10,13-16,18H2,1-2H3 USIWFTPEBGPOSA-UHFFFAOYSA-N 50213537 3,4-dimethoxy-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228389 D(2) dopamine receptor Homo sapiens 83 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213537&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857709 104088886 CHEMBL228389 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387046 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.65,-7.4,;9.11,-7.39,;8.33,-8.72,;6.77,-8.72,;6,-10.07,;6.76,-11.39,;8.32,-11.39,;9.08,-10.07,;10.62,-10.08,;11.38,-11.42,;5.99,-12.74,;4.67,-11.97,;7.35,-13.51,;5.23,-14.04,;3.66,-14.04,;2.9,-15.36,;1.38,-15.36,;.6,-14.01,;1.37,-12.69,;2.9,-12.73,;-.96,-14.01,;-1.73,-15.34,;-3.26,-15.34,;-4.03,-13.99,;-3.26,-12.66,;-1.73,-12.69,;-5.59,-13.99,;-6.36,-15.33,;-7.9,-15.33,;-8.67,-13.98,;-7.89,-12.66,;-6.36,-12.66,;-5.59,-11.31,;-6.36,-9.98,;-5.59,-8.65,;-4.83,-7.3,;-4.25,-9.41,;-6.93,-7.89,)| InChI=1S/C27H35F3N2O5S/c1-35-25-12-11-22(17-26(25)36-2)38(33,34)31-20-7-9-21(10-8-20)32-15-13-19(14-16-32)23-5-3-4-6-24(23)37-18-27(28,29)30/h3-6,11-12,17,19-21,31H,7-10,13-16,18H2,1-2H3 USIWFTPEBGPOSA-UHFFFAOYSA-N 50213525 3,4-dimethoxy-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228334 D(2) dopamine receptor Homo sapiens 111 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213525&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857709 104088874 CHEMBL228334 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387047 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:17.21,wD:14.14,(32.87,-18.24,;31.33,-18.26,;30.57,-19.6,;29.02,-19.61,;28.27,-20.96,;29.05,-22.28,;30.59,-22.27,;31.35,-20.93,;32.89,-20.92,;33.67,-22.24,;28.29,-23.62,;26.94,-22.88,;29.64,-24.36,;27.57,-24.98,;26.03,-25.04,;25.21,-23.74,;23.67,-23.79,;22.96,-25.16,;23.78,-26.46,;25.31,-26.4,;21.42,-25.21,;20.7,-26.58,;19.17,-26.64,;18.34,-25.34,;19.05,-23.98,;20.59,-23.91,;16.81,-25.41,;16.09,-26.78,;14.55,-26.84,;13.73,-25.54,;14.43,-24.18,;15.97,-24.1,;16.67,-22.73,;15.84,-21.44,;15.77,-19.91,;14.47,-20.74,)| InChI=1S/C28H38N2O5S/c1-33-27-14-13-24(19-28(27)34-2)36(31,32)29-21-7-9-22(10-8-21)30-17-15-20(16-18-30)25-5-3-4-6-26(25)35-23-11-12-23/h3-6,13-14,19-23,29H,7-12,15-18H2,1-2H3 JFRXSPVSGNWHOD-UHFFFAOYSA-N 50213513 N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228278 Alpha-1B adrenergic receptor Homo sapiens 133 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213513&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11519153 104088862 CHEMBL228278 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387048 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCCF |wU:17.21,14.14,(9.78,-22.9,;8.24,-22.89,;7.46,-24.22,;5.9,-24.22,;5.13,-25.56,;5.89,-26.89,;7.45,-26.89,;8.21,-25.57,;9.75,-25.58,;10.52,-26.91,;5.12,-28.23,;3.8,-27.47,;6.48,-29.01,;4.36,-29.54,;2.79,-29.54,;2.03,-30.86,;.51,-30.86,;-.27,-29.51,;.5,-28.19,;2.03,-28.23,;-1.84,-29.51,;-2.6,-30.83,;-4.13,-30.83,;-4.91,-29.49,;-4.14,-28.16,;-2.6,-28.19,;-6.46,-29.49,;-7.23,-30.83,;-8.77,-30.83,;-9.55,-29.48,;-8.76,-28.16,;-7.24,-28.16,;-6.46,-26.81,;-7.23,-25.48,;-6.46,-24.14,;-7.23,-22.81,)| InChI=1S/C27H37FN2O5S/c1-33-26-12-11-23(19-27(26)34-2)36(31,32)29-21-7-9-22(10-8-21)30-16-13-20(14-17-30)24-5-3-4-6-25(24)35-18-15-28/h3-6,11-12,19-22,29H,7-10,13-18H2,1-2H3 NZOIFXLLVJGITJ-UHFFFAOYSA-N 50213536 N-((1s,4s)-4-(4-(2-(2-fluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL538397 D(2) dopamine receptor Homo sapiens 201 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213536&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857861 104088885 CHEMBL538397 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387049 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)F |wU:17.21,wD:14.14,(32.79,-36.92,;31.25,-36.91,;30.47,-38.24,;28.91,-38.24,;28.14,-39.59,;28.9,-40.91,;30.46,-40.91,;31.23,-39.59,;32.77,-39.6,;33.53,-40.94,;28.13,-42.25,;26.81,-41.49,;29.49,-43.03,;27.38,-43.56,;25.8,-43.56,;25.04,-42.25,;23.51,-42.21,;22.75,-43.53,;23.52,-44.88,;25.04,-44.88,;21.18,-43.53,;20.41,-44.86,;18.88,-44.86,;18.11,-43.51,;18.88,-42.18,;20.41,-42.21,;16.55,-43.51,;15.78,-44.85,;14.24,-44.85,;13.47,-43.5,;14.25,-42.18,;15.78,-42.18,;16.55,-40.83,;15.78,-39.5,;16.55,-38.16,;15.78,-36.83,;18.09,-38.16,)| InChI=1S/C27H36F2N2O5S/c1-34-25-12-11-22(17-26(25)35-2)37(32,33)30-20-7-9-21(10-8-20)31-15-13-19(14-16-31)23-5-3-4-6-24(23)36-18-27(28)29/h3-6,11-12,17,19-21,27,30H,7-10,13-16,18H2,1-2H3 QLLKZBYEHJGRHK-UHFFFAOYSA-N 50213533 N-((1r,4r)-4-(4-(2-(2,2-difluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228607 Alpha-1D adrenergic receptor Homo sapiens 86 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213533&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857862 104088882 CHEMBL228607 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387050 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(31.88,-7.8,;30.34,-7.79,;29.56,-9.12,;28,-9.12,;27.23,-10.47,;27.99,-11.79,;29.55,-11.79,;30.32,-10.47,;31.86,-10.48,;32.62,-11.82,;27.22,-13.13,;25.9,-12.37,;28.58,-13.91,;26.47,-14.44,;24.89,-14.44,;24.14,-13.13,;22.6,-13.09,;21.84,-14.41,;22.61,-15.76,;24.13,-15.76,;20.27,-14.41,;19.5,-15.73,;17.98,-15.73,;17.2,-14.39,;17.97,-13.06,;19.51,-13.09,;15.65,-14.39,;14.87,-15.72,;13.33,-15.72,;12.56,-14.38,;13.35,-13.06,;14.87,-13.06,;15.65,-11.71,;14.88,-10.38,;15.64,-9.04,;16.4,-7.7,;16.98,-9.81,;14.31,-8.28,)| InChI=1S/C27H35F3N2O5S/c1-35-25-12-11-22(17-26(25)36-2)38(33,34)31-20-7-9-21(10-8-20)32-15-13-19(14-16-32)23-5-3-4-6-24(23)37-18-27(28,29)30/h3-6,11-12,17,19-21,31H,7-10,13-16,18H2,1-2H3 USIWFTPEBGPOSA-UHFFFAOYSA-N 50213537 3,4-dimethoxy-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228389 Alpha-1A adrenergic receptor Homo sapiens 21 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213537&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857709 104088886 CHEMBL228389 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387051 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC(C)C |wU:17.21,wD:14.14,(30.34,5.31,;28.8,5.3,;28.05,3.95,;26.49,3.94,;25.74,2.59,;26.52,1.27,;28.07,1.28,;28.83,2.62,;30.37,2.64,;31.15,1.31,;25.76,-.07,;24.41,.67,;27.11,-.81,;25.04,-1.43,;23.51,-1.49,;22.68,-.18,;21.14,-.24,;20.43,-1.6,;21.25,-2.91,;22.79,-2.85,;18.9,-1.66,;18.18,-3.02,;16.65,-3.09,;15.82,-1.79,;16.53,-.42,;18.07,-.36,;14.28,-1.85,;13.57,-3.22,;12.03,-3.29,;11.2,-1.99,;11.91,-.62,;13.45,-.55,;14.15,.82,;13.32,2.11,;14.03,3.48,;11.78,2.04,)| InChI=1S/C28H40N2O5S/c1-20(2)35-26-8-6-5-7-25(26)21-15-17-30(18-16-21)23-11-9-22(10-12-23)29-36(31,32)24-13-14-27(33-3)28(19-24)34-4/h5-8,13-14,19-23,29H,9-12,15-18H2,1-4H3 ACYCBNFGNBHQEP-UHFFFAOYSA-N 50213524 N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL388361 Alpha-1A adrenergic receptor Homo sapiens 28 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213524&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857638 104088873 CHEMBL388361 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387052 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:15.19,wD:12.12,(31.74,-46.23,;30.97,-44.89,;31.73,-43.57,;30.98,-42.22,;29.42,-42.22,;28.65,-40.89,;28.65,-43.57,;29.41,-44.89,;28.64,-46.24,;27.32,-45.47,;30,-47.01,;27.88,-47.54,;26.31,-47.54,;25.55,-46.24,;24.01,-46.19,;23.25,-47.51,;24.03,-48.86,;25.55,-48.86,;21.68,-47.51,;20.91,-48.84,;19.39,-48.84,;18.61,-47.49,;19.38,-46.16,;20.92,-46.19,;17.06,-47.49,;16.28,-48.83,;14.74,-48.83,;13.97,-47.48,;14.76,-46.16,;16.28,-46.16,;17.06,-44.82,;16.29,-43.48,;17.06,-42.15,;17.82,-40.8,;18.39,-42.91,;15.72,-41.39,)| InChI=1S/C25H29ClF4N2O3S/c26-18-5-10-22(27)24(15-18)36(33,34)31-19-6-8-20(9-7-19)32-13-11-17(12-14-32)21-3-1-2-4-23(21)35-16-25(28,29)30/h1-5,10,15,17,19-20,31H,6-9,11-14,16H2 HNTIGZIKHBPAFD-UHFFFAOYSA-N 50213535 5-chloro-2-fluoro-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228494 Alpha-1D adrenergic receptor Homo sapiens 44 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213535&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857793 104088884 CHEMBL228494 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387053 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:16.20,13.13,(10.04,-34.29,;8.5,-34.3,;7.72,-32.97,;8.48,-31.63,;7.7,-30.3,;6.15,-30.32,;5.37,-29,;5.4,-31.66,;6.18,-32.98,;5.42,-34.32,;4.07,-33.59,;6.77,-35.07,;4.7,-35.69,;3.16,-35.74,;2.44,-37.1,;.91,-37.16,;.09,-35.86,;.8,-34.5,;2.34,-34.44,;-1.45,-35.92,;-2.16,-37.28,;-3.7,-37.35,;-4.52,-36.05,;-3.82,-34.68,;-2.28,-34.62,;-6.06,-36.11,;-6.77,-37.48,;-8.31,-37.55,;-9.14,-36.24,;-8.43,-34.88,;-6.9,-34.81,;-6.19,-33.44,;-7.02,-32.14,;-7.1,-30.6,;-8.39,-31.43,)| InChI=1S/C27H35ClN2O4S/c1-33-26-13-6-20(28)18-27(26)35(31,32)29-21-7-9-22(10-8-21)30-16-14-19(15-17-30)24-4-2-3-5-25(24)34-23-11-12-23/h2-6,13,18-19,21-23,29H,7-12,14-17H2,1H3 CQABPCACTMBCQC-UHFFFAOYSA-N 50213512 5-chloro-N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-methoxybenzenesulfonamide::CHEMBL388897 D(2) dopamine receptor Homo sapiens 129 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213512&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857710 104088861 CHEMBL388897 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387054 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:15.19,12.12,(8.56,-46.34,;7.79,-45.01,;8.56,-43.69,;7.8,-42.34,;6.24,-42.34,;5.47,-41.01,;5.47,-43.69,;6.23,-45.01,;5.46,-46.35,;4.14,-45.59,;6.82,-47.13,;4.71,-47.66,;3.13,-47.66,;2.37,-48.98,;.85,-48.98,;.08,-47.63,;.84,-46.31,;2.37,-46.35,;-1.49,-47.63,;-2.26,-48.96,;-3.79,-48.96,;-4.56,-47.61,;-3.79,-46.28,;-2.26,-46.31,;-6.12,-47.61,;-6.89,-48.95,;-8.43,-48.95,;-9.2,-47.6,;-8.42,-46.28,;-6.89,-46.28,;-6.12,-44.93,;-6.89,-43.6,;-6.12,-42.27,;-5.36,-40.92,;-4.78,-43.03,;-7.46,-41.5,)| InChI=1S/C25H29ClF4N2O3S/c26-18-5-10-22(27)24(15-18)36(33,34)31-19-6-8-20(9-7-19)32-13-11-17(12-14-32)21-3-1-2-4-23(21)35-16-25(28,29)30/h1-5,10,15,17,19-20,31H,6-9,11-14,16H2 HNTIGZIKHBPAFD-UHFFFAOYSA-N 50213529 5-chloro-2-fluoro-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228445 Alpha-1A adrenergic receptor Homo sapiens 5.9 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213529&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857793 104088878 CHEMBL228445 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387055 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1cc(F)ccc1OC(C)C |wU:17.21,wD:14.14,(32.28,-7.61,;30.74,-7.6,;29.96,-8.93,;28.4,-8.93,;27.63,-10.28,;28.39,-11.6,;29.95,-11.6,;30.71,-10.28,;32.25,-10.29,;33.01,-11.63,;27.62,-12.95,;26.3,-12.18,;28.98,-13.72,;26.86,-14.25,;25.29,-14.25,;24.53,-12.94,;23,-12.9,;22.23,-14.22,;23.01,-15.57,;24.53,-15.57,;20.67,-14.22,;19.9,-15.55,;18.37,-15.55,;17.6,-14.2,;18.37,-12.87,;19.9,-12.9,;16.04,-14.2,;15.27,-15.54,;13.73,-15.54,;12.96,-16.87,;12.96,-14.19,;13.74,-12.87,;15.27,-12.87,;16.04,-11.52,;15.27,-10.19,;16.04,-8.86,;13.73,-10.19,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-26-11-5-21(29)17-25(26)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-27(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 AEJCTJSNUNXYQL-UHFFFAOYSA-N 50213539 N-((1r,4r)-4-(4-(5-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL390473 Alpha-1B adrenergic receptor Homo sapiens 1487 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213539&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857864 104088888 CHEMBL390473 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387056 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCCF |wU:17.21,14.14,(9.78,-22.9,;8.24,-22.89,;7.46,-24.22,;5.9,-24.22,;5.13,-25.56,;5.89,-26.89,;7.45,-26.89,;8.21,-25.57,;9.75,-25.58,;10.52,-26.91,;5.12,-28.23,;3.8,-27.47,;6.48,-29.01,;4.36,-29.54,;2.79,-29.54,;2.03,-30.86,;.51,-30.86,;-.27,-29.51,;.5,-28.19,;2.03,-28.23,;-1.84,-29.51,;-2.6,-30.83,;-4.13,-30.83,;-4.91,-29.49,;-4.14,-28.16,;-2.6,-28.19,;-6.46,-29.49,;-7.23,-30.83,;-8.77,-30.83,;-9.55,-29.48,;-8.76,-28.16,;-7.24,-28.16,;-6.46,-26.81,;-7.23,-25.48,;-6.46,-24.14,;-7.23,-22.81,)| InChI=1S/C27H37FN2O5S/c1-33-26-12-11-23(19-27(26)34-2)36(31,32)29-21-7-9-22(10-8-21)30-16-13-20(14-17-30)24-5-3-4-6-25(24)35-18-15-28/h3-6,11-12,19-22,29H,7-10,13-18H2,1-2H3 NZOIFXLLVJGITJ-UHFFFAOYSA-N 50213536 N-((1s,4s)-4-(4-(2-(2-fluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL538397 Alpha-1B adrenergic receptor Homo sapiens 401 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213536&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857861 104088885 CHEMBL538397 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387057 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1cc(F)ccc1OC(C)C |wU:17.21,14.14,(10.23,-7.86,;8.69,-7.85,;7.91,-9.18,;6.36,-9.18,;5.59,-10.53,;6.35,-11.85,;7.91,-11.85,;8.67,-10.53,;10.21,-10.54,;10.97,-11.88,;5.58,-13.19,;4.26,-12.43,;6.94,-13.97,;4.82,-14.5,;3.25,-14.5,;2.49,-15.82,;.97,-15.82,;.19,-14.47,;.96,-13.15,;2.49,-13.19,;-1.38,-14.47,;-2.14,-15.8,;-3.67,-15.8,;-4.45,-14.45,;-3.67,-13.12,;-2.14,-13.15,;-6,-14.45,;-6.77,-15.79,;-8.31,-15.79,;-9.08,-17.12,;-9.08,-14.44,;-8.3,-13.12,;-6.77,-13.12,;-6,-11.77,;-6.77,-10.44,;-6,-9.11,;-8.31,-10.44,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-26-11-5-21(29)17-25(26)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-27(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 AEJCTJSNUNXYQL-UHFFFAOYSA-N 50213530 N-((1s,4s)-4-(4-(5-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228659 Alpha-1D adrenergic receptor Homo sapiens 1.6 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213530&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857864 104088879 CHEMBL228659 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387058 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.42,6.24,;7.88,6.23,;7.12,4.89,;5.57,4.87,;4.82,3.53,;5.6,2.21,;7.14,2.22,;7.9,3.56,;9.44,3.57,;10.22,2.24,;4.84,.87,;3.49,1.6,;6.19,.12,;4.12,-.5,;2.58,-.55,;1.86,-1.91,;.33,-1.97,;-.49,-.67,;.22,.69,;1.76,.75,;-2.03,-.73,;-2.75,-2.09,;-4.28,-2.16,;-5.11,-.86,;-4.4,.51,;-2.86,.57,;-6.64,-.92,;-7.36,-2.29,;-8.9,-2.36,;-9.72,-1.05,;-9.02,.31,;-7.48,.38,;-6.78,1.75,;-7.61,3.05,;-6.9,4.41,;-9.15,2.97,)| InChI=1S/C28H40N2O5S/c1-20(2)35-26-8-6-5-7-25(26)21-15-17-30(18-16-21)23-11-9-22(10-12-23)29-36(31,32)24-13-14-27(33-3)28(19-24)34-4/h5-8,13-14,19-23,29H,9-12,15-18H2,1-4H3 ACYCBNFGNBHQEP-UHFFFAOYSA-N 50213521 N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL390129 Alpha-1B adrenergic receptor Homo sapiens 144 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213521&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857638 104088870 CHEMBL390129 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387059 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:16.20,wD:13.13,(33.93,-35.76,;32.39,-35.76,;31.62,-34.43,;32.38,-33.1,;31.63,-31.76,;30.07,-31.76,;29.3,-30.42,;29.3,-33.1,;30.06,-34.43,;29.29,-35.77,;27.97,-35.01,;30.65,-36.55,;28.53,-37.08,;26.96,-37.08,;26.2,-35.77,;24.67,-35.73,;23.9,-37.04,;24.68,-38.4,;26.2,-38.4,;22.33,-37.04,;21.57,-38.37,;20.04,-38.37,;19.26,-37.03,;20.03,-35.69,;21.57,-35.73,;17.71,-37.03,;16.94,-38.36,;15.4,-38.36,;14.62,-37.01,;15.41,-35.69,;16.93,-35.69,;17.71,-34.35,;16.94,-33.02,;17.71,-31.68,;18.47,-30.34,;19.05,-32.44,;16.37,-30.92,)| InChI=1S/C26H32ClF3N2O4S/c1-35-24-11-6-19(27)16-25(24)37(33,34)31-20-7-9-21(10-8-20)32-14-12-18(13-15-32)22-4-2-3-5-23(22)36-17-26(28,29)30/h2-6,11,16,18,20-21,31H,7-10,12-15,17H2,1H3 WDZOSSNSOBKEMP-UHFFFAOYSA-N 50213515 5-chloro-2-methoxy-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL390192 Alpha-1B adrenergic receptor Homo sapiens 703 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213515&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857792 104088864 CHEMBL390192 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387060 FC(F)(F)COc1ccccc1C1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc2OCCOc2c1 |wU:18.19,wD:21.26,(18.05,-19.16,;17.29,-20.51,;18.63,-21.27,;15.95,-19.75,;16.52,-21.84,;17.3,-23.18,;16.52,-24.52,;15,-24.52,;14.21,-25.84,;14.98,-27.19,;16.52,-27.19,;17.3,-25.85,;18.85,-25.85,;19.62,-27.2,;21.15,-27.2,;21.92,-25.87,;21.16,-24.55,;19.62,-24.52,;23.49,-25.87,;24.25,-24.55,;25.78,-24.59,;26.54,-25.9,;25.78,-27.22,;24.26,-27.22,;28.12,-25.9,;28.87,-24.6,;27.55,-23.83,;30.23,-25.37,;29.64,-23.25,;28.88,-21.93,;29.65,-20.58,;31.21,-20.58,;31.99,-19.25,;33.53,-19.26,;34.29,-20.6,;33.51,-21.93,;31.96,-21.93,;31.2,-23.25,)| InChI=1S/C27H33F3N2O5S/c28-27(29,30)18-37-24-4-2-1-3-23(24)19-11-13-32(14-12-19)21-7-5-20(6-8-21)31-38(33,34)22-9-10-25-26(17-22)36-16-15-35-25/h1-4,9-10,17,19-21,31H,5-8,11-16,18H2 PPAIEDLGYFCKEB-UHFFFAOYSA-N 50213527 N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide::CHEMBL228390 Alpha-1B adrenergic receptor Homo sapiens 91 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213527&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857791 104088876 CHEMBL228390 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387061 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.65,-7.4,;9.11,-7.39,;8.33,-8.72,;6.77,-8.72,;6,-10.07,;6.76,-11.39,;8.32,-11.39,;9.08,-10.07,;10.62,-10.08,;11.38,-11.42,;5.99,-12.74,;4.67,-11.97,;7.35,-13.51,;5.23,-14.04,;3.66,-14.04,;2.9,-15.36,;1.38,-15.36,;.6,-14.01,;1.37,-12.69,;2.9,-12.73,;-.96,-14.01,;-1.73,-15.34,;-3.26,-15.34,;-4.03,-13.99,;-3.26,-12.66,;-1.73,-12.69,;-5.59,-13.99,;-6.36,-15.33,;-7.9,-15.33,;-8.67,-13.98,;-7.89,-12.66,;-6.36,-12.66,;-5.59,-11.31,;-6.36,-9.98,;-5.59,-8.65,;-4.83,-7.3,;-4.25,-9.41,;-6.93,-7.89,)| InChI=1S/C27H35F3N2O5S/c1-35-25-12-11-22(17-26(25)36-2)38(33,34)31-20-7-9-21(10-8-20)32-15-13-19(14-16-32)23-5-3-4-6-24(23)37-18-27(28,29)30/h3-6,11-12,17,19-21,31H,7-10,13-16,18H2,1-2H3 USIWFTPEBGPOSA-UHFFFAOYSA-N 50213525 3,4-dimethoxy-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228334 Alpha-1D adrenergic receptor Homo sapiens 2.2 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213525&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857709 104088874 CHEMBL228334 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387062 FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.92,.29,;9.38,.29,;8.6,-1.03,;8.62,1.63,;7.08,1.64,;6.32,2.99,;4.76,2.99,;3.99,1.64,;4.75,.32,;6.32,.32,;3.98,-1.02,;2.66,-.26,;5.34,-1.8,;3.23,-2.33,;1.65,-2.33,;.89,-3.65,;-.63,-3.65,;-1.4,-2.3,;-.64,-.98,;.9,-1.02,;-2.97,-2.3,;-3.74,-3.62,;-5.27,-3.62,;-6.04,-2.28,;-5.27,-.95,;-3.73,-.98,;-7.59,-2.28,;-8.37,-3.62,;-9.91,-3.62,;-10.68,-2.27,;-9.89,-.95,;-8.37,-.95,;-7.59,.4,;-8.37,1.73,;-7.6,3.07,;-6.84,4.41,;-6.26,2.3,;-8.94,3.83,)| InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2 RVPGPLCUKORXKA-UHFFFAOYSA-N 50213520 3-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228496 Alpha-1A adrenergic receptor Homo sapiens 7 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213520&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857794 104088869 CHEMBL228496 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387063 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCCF |wU:17.21,wD:14.14,(31.66,-22.48,;30.12,-22.47,;29.34,-23.8,;27.78,-23.8,;27.01,-25.15,;27.77,-26.47,;29.33,-26.47,;30.09,-25.15,;31.63,-25.16,;32.4,-26.5,;27,-27.82,;25.68,-27.05,;28.36,-28.59,;26.24,-29.13,;24.67,-29.13,;23.91,-27.82,;22.38,-27.77,;21.61,-29.09,;22.39,-30.44,;23.91,-30.44,;20.04,-29.09,;19.28,-30.42,;17.75,-30.42,;16.97,-29.08,;17.74,-27.74,;19.28,-27.77,;15.42,-29.08,;14.64,-30.41,;13.1,-30.41,;12.33,-29.06,;13.12,-27.74,;14.64,-27.74,;15.42,-26.4,;14.65,-25.06,;15.42,-23.73,;14.65,-22.4,)| InChI=1S/C27H37FN2O5S/c1-33-26-12-11-23(19-27(26)34-2)36(31,32)29-21-7-9-22(10-8-21)30-16-13-20(14-17-30)24-5-3-4-6-25(24)35-18-15-28/h3-6,11-12,19-22,29H,7-10,13-18H2,1-2H3 NZOIFXLLVJGITJ-UHFFFAOYSA-N 50213519 N-((1r,4r)-4-(4-(2-(2-fluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228606 Alpha-1B adrenergic receptor Homo sapiens 4403 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213519&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857861 104088868 CHEMBL228606 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387064 O=S(=O)(N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1)c1ccc2OCOc2c1 |wU:7.10,wD:4.3,(26.12,.88,;27.45,.11,;28.8,-.66,;26.69,-1.19,;25.12,-1.19,;24.36,.12,;22.82,.16,;22.06,-1.16,;22.84,-2.51,;24.36,-2.51,;20.49,-1.16,;19.73,-2.49,;18.2,-2.49,;17.43,-1.14,;18.2,.19,;19.73,.16,;15.87,-1.14,;15.1,-2.48,;13.56,-2.48,;12.79,-1.13,;13.57,.19,;15.1,.19,;15.87,1.53,;15.11,2.87,;15.11,4.42,;13.77,3.64,;28.21,1.46,;27.45,2.78,;28.22,4.13,;29.78,4.13,;30.82,5.26,;32.23,4.63,;32.06,3.09,;30.54,2.78,;29.78,1.46,)| InChI=1S/C27H34N2O5S/c30-35(31,23-11-12-26-27(17-23)33-18-32-26)28-20-5-7-21(8-6-20)29-15-13-19(14-16-29)24-3-1-2-4-25(24)34-22-9-10-22/h1-4,11-12,17,19-22,28H,5-10,13-16,18H2 ZIIYCNPQTIYWFF-UHFFFAOYSA-N 50213534 N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzo[d][1,3]dioxole-5-sulfonamide::CHEMBL228333 Alpha-1B adrenergic receptor Homo sapiens 340 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213534&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426404 104088883 CHEMBL228333 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387065 FC(F)(F)COc1ccccc1C1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc2OCCOc2c1 |wU:18.19,wD:21.26,(18.05,-19.16,;17.29,-20.51,;18.63,-21.27,;15.95,-19.75,;16.52,-21.84,;17.3,-23.18,;16.52,-24.52,;15,-24.52,;14.21,-25.84,;14.98,-27.19,;16.52,-27.19,;17.3,-25.85,;18.85,-25.85,;19.62,-27.2,;21.15,-27.2,;21.92,-25.87,;21.16,-24.55,;19.62,-24.52,;23.49,-25.87,;24.25,-24.55,;25.78,-24.59,;26.54,-25.9,;25.78,-27.22,;24.26,-27.22,;28.12,-25.9,;28.87,-24.6,;27.55,-23.83,;30.23,-25.37,;29.64,-23.25,;28.88,-21.93,;29.65,-20.58,;31.21,-20.58,;31.99,-19.25,;33.53,-19.26,;34.29,-20.6,;33.51,-21.93,;31.96,-21.93,;31.2,-23.25,)| InChI=1S/C27H33F3N2O5S/c28-27(29,30)18-37-24-4-2-1-3-23(24)19-11-13-32(14-12-19)21-7-5-20(6-8-21)31-38(33,34)22-9-10-25-26(17-22)36-16-15-35-25/h1-4,9-10,17,19-21,31H,5-8,11-16,18H2 PPAIEDLGYFCKEB-UHFFFAOYSA-N 50213527 N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide::CHEMBL228390 Alpha-1A adrenergic receptor Homo sapiens 2.2 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213527&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857791 104088876 CHEMBL228390 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387066 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:15.19,12.12,(9.95,-45.7,;9.18,-44.37,;9.94,-43.03,;9.15,-41.7,;7.6,-41.72,;6.82,-40.4,;6.85,-43.06,;7.63,-44.38,;6.87,-45.72,;5.52,-44.99,;8.22,-46.47,;6.15,-47.08,;4.62,-47.14,;3.89,-48.5,;2.36,-48.56,;1.54,-47.26,;2.25,-45.9,;3.79,-45.84,;.01,-47.32,;-.71,-48.68,;-2.24,-48.74,;-3.07,-47.44,;-2.36,-46.08,;-.82,-46.02,;-4.61,-47.51,;-5.32,-48.88,;-6.86,-48.95,;-7.68,-47.64,;-6.98,-46.28,;-5.44,-46.21,;-4.74,-44.84,;-5.57,-43.54,;-5.64,-42,;-6.94,-42.83,)| InChI=1S/C26H32ClFN2O3S/c27-19-5-12-24(28)26(17-19)34(31,32)29-20-6-8-21(9-7-20)30-15-13-18(14-16-30)23-3-1-2-4-25(23)33-22-10-11-22/h1-5,12,17-18,20-22,29H,6-11,13-16H2 LVDRNYWTLKUNNT-UHFFFAOYSA-N 50213538 5-chloro-N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-fluorobenzenesulfonamide::CHEMBL228280 Alpha-1D adrenergic receptor Homo sapiens 2.1 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213538&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857711 104088887 CHEMBL228280 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387067 CC(C)Oc1ccccc1C1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc(F)c(F)c1 |wU:16.17,wD:19.24,(14.85,-7.42,;14.15,-8.79,;12.61,-8.86,;14.98,-10.08,;14.27,-11.45,;12.74,-11.52,;12.03,-12.89,;12.86,-14.19,;14.4,-14.12,;15.11,-12.75,;16.65,-12.69,;17.47,-13.99,;19,-13.92,;19.72,-12.56,;18.89,-11.26,;17.35,-11.32,;21.26,-12.5,;21.97,-11.14,;23.51,-11.08,;24.33,-12.39,;23.61,-13.75,;22.08,-13.81,;25.87,-12.33,;26.59,-10.97,;25.24,-10.23,;27.94,-11.71,;27.35,-9.62,;26.57,-8.3,;27.32,-6.96,;28.87,-6.94,;29.63,-5.6,;29.65,-8.28,;31.19,-8.26,;28.89,-9.62,)| InChI=1S/C26H34F2N2O3S/c1-18(2)33-26-6-4-3-5-23(26)19-13-15-30(16-14-19)21-9-7-20(8-10-21)29-34(31,32)22-11-12-24(27)25(28)17-22/h3-6,11-12,17-21,29H,7-10,13-16H2,1-2H3 NHRXMVNDSUMAIN-UHFFFAOYSA-N 50213518 3,4-difluoro-N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL229084 Alpha-1D adrenergic receptor Homo sapiens 87 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213518&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857639 104088867 CHEMBL229084 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387068 O=S(=O)(N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1)c1ccc2OCOc2c1 |wU:7.10,wD:4.3,(26.12,.88,;27.45,.11,;28.8,-.66,;26.69,-1.19,;25.12,-1.19,;24.36,.12,;22.82,.16,;22.06,-1.16,;22.84,-2.51,;24.36,-2.51,;20.49,-1.16,;19.73,-2.49,;18.2,-2.49,;17.43,-1.14,;18.2,.19,;19.73,.16,;15.87,-1.14,;15.1,-2.48,;13.56,-2.48,;12.79,-1.13,;13.57,.19,;15.1,.19,;15.87,1.53,;15.11,2.87,;15.11,4.42,;13.77,3.64,;28.21,1.46,;27.45,2.78,;28.22,4.13,;29.78,4.13,;30.82,5.26,;32.23,4.63,;32.06,3.09,;30.54,2.78,;29.78,1.46,)| InChI=1S/C27H34N2O5S/c30-35(31,23-11-12-26-27(17-23)33-18-32-26)28-20-5-7-21(8-6-20)29-15-13-19(14-16-29)24-3-1-2-4-25(24)34-22-9-10-22/h1-4,11-12,17,19-22,28H,5-10,13-16,18H2 ZIIYCNPQTIYWFF-UHFFFAOYSA-N 50213534 N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzo[d][1,3]dioxole-5-sulfonamide::CHEMBL228333 Alpha-1A adrenergic receptor Homo sapiens 14 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213534&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426404 104088883 CHEMBL228333 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387069 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:15.19,wD:12.12,(31.96,-44.68,;31.18,-43.35,;31.94,-42.01,;31.16,-40.68,;29.61,-40.69,;28.82,-39.37,;28.85,-42.04,;29.64,-43.36,;28.88,-44.7,;27.52,-43.96,;30.22,-45.44,;28.16,-46.06,;26.62,-46.12,;25.8,-44.81,;24.25,-44.87,;23.54,-46.24,;24.37,-47.54,;25.9,-47.48,;22.01,-46.29,;21.29,-47.66,;19.76,-47.72,;18.93,-46.42,;19.64,-45.05,;21.18,-44.99,;17.39,-46.49,;16.68,-47.85,;15.14,-47.92,;14.31,-46.62,;15.02,-45.26,;16.56,-45.18,;17.26,-43.81,;16.43,-42.52,;16.36,-40.99,;15.06,-41.82,)| InChI=1S/C26H32ClFN2O3S/c27-19-5-12-24(28)26(17-19)34(31,32)29-20-6-8-21(9-7-20)30-15-13-18(14-16-30)23-3-1-2-4-25(23)33-22-10-11-22/h1-5,12,17-18,20-22,29H,6-11,13-16H2 LVDRNYWTLKUNNT-UHFFFAOYSA-N 50213510 5-chloro-N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-fluorobenzenesulfonamide::CHEMBL228332 Alpha-1A adrenergic receptor Homo sapiens 3.8 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213510&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857711 104088859 CHEMBL228332 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387070 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1cc(F)ccc1OC(C)C |wU:17.21,wD:14.14,(32.28,-7.61,;30.74,-7.6,;29.96,-8.93,;28.4,-8.93,;27.63,-10.28,;28.39,-11.6,;29.95,-11.6,;30.71,-10.28,;32.25,-10.29,;33.01,-11.63,;27.62,-12.95,;26.3,-12.18,;28.98,-13.72,;26.86,-14.25,;25.29,-14.25,;24.53,-12.94,;23,-12.9,;22.23,-14.22,;23.01,-15.57,;24.53,-15.57,;20.67,-14.22,;19.9,-15.55,;18.37,-15.55,;17.6,-14.2,;18.37,-12.87,;19.9,-12.9,;16.04,-14.2,;15.27,-15.54,;13.73,-15.54,;12.96,-16.87,;12.96,-14.19,;13.74,-12.87,;15.27,-12.87,;16.04,-11.52,;15.27,-10.19,;16.04,-8.86,;13.73,-10.19,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-26-11-5-21(29)17-25(26)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-27(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 AEJCTJSNUNXYQL-UHFFFAOYSA-N 50213539 N-((1r,4r)-4-(4-(5-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL390473 Alpha-1D adrenergic receptor Homo sapiens 53 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213539&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857864 104088888 CHEMBL390473 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387071 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1cc(F)ccc1OC(C)C |wU:17.21,wD:14.14,(32.28,-7.61,;30.74,-7.6,;29.96,-8.93,;28.4,-8.93,;27.63,-10.28,;28.39,-11.6,;29.95,-11.6,;30.71,-10.28,;32.25,-10.29,;33.01,-11.63,;27.62,-12.95,;26.3,-12.18,;28.98,-13.72,;26.86,-14.25,;25.29,-14.25,;24.53,-12.94,;23,-12.9,;22.23,-14.22,;23.01,-15.57,;24.53,-15.57,;20.67,-14.22,;19.9,-15.55,;18.37,-15.55,;17.6,-14.2,;18.37,-12.87,;19.9,-12.9,;16.04,-14.2,;15.27,-15.54,;13.73,-15.54,;12.96,-16.87,;12.96,-14.19,;13.74,-12.87,;15.27,-12.87,;16.04,-11.52,;15.27,-10.19,;16.04,-8.86,;13.73,-10.19,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-26-11-5-21(29)17-25(26)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-27(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 AEJCTJSNUNXYQL-UHFFFAOYSA-N 50213539 N-((1r,4r)-4-(4-(5-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL390473 D(2) dopamine receptor Homo sapiens 94 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213539&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857864 104088888 CHEMBL390473 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387072 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)F |wU:17.21,14.14,(10.25,-37,;8.71,-36.99,;7.93,-38.32,;6.37,-38.32,;5.6,-39.66,;6.36,-40.99,;7.93,-40.99,;8.69,-39.66,;10.23,-39.67,;10.99,-41.01,;5.59,-42.33,;4.27,-41.57,;6.95,-43.11,;4.84,-43.64,;3.26,-43.64,;2.5,-44.96,;.98,-44.96,;.21,-43.6,;.97,-42.29,;2.51,-42.33,;-1.36,-43.6,;-2.13,-44.93,;-3.66,-44.93,;-4.43,-43.59,;-3.66,-42.25,;-2.12,-42.29,;-5.98,-43.59,;-6.76,-44.92,;-8.3,-44.92,;-9.07,-43.58,;-8.29,-42.25,;-6.76,-42.25,;-5.98,-40.91,;-6.76,-39.58,;-5.99,-38.24,;-6.76,-36.91,;-4.45,-38.24,)| InChI=1S/C27H36F2N2O5S/c1-34-25-12-11-22(17-26(25)35-2)37(32,33)30-20-7-9-21(10-8-20)31-15-13-19(14-16-31)23-5-3-4-6-24(23)36-18-27(28)29/h3-6,11-12,17,19-21,27,30H,7-10,13-16,18H2,1-2H3 QLLKZBYEHJGRHK-UHFFFAOYSA-N 50213523 N-((1s,4s)-4-(4-(2-(2,2-difluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL387833 Alpha-1A adrenergic receptor Homo sapiens 12 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213523&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857862 104088872 CHEMBL387833 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387073 O=S(=O)(N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1)c1ccc2OCOc2c1 |wU:7.10,4.3,(4.39,.82,;5.71,.06,;7.07,-.72,;4.95,-1.25,;3.38,-1.25,;2.62,-2.57,;1.1,-2.57,;.32,-1.21,;1.09,.1,;2.62,.06,;-1.24,-1.21,;-2.01,-2.54,;-3.54,-2.54,;-4.31,-1.2,;-3.54,.13,;-2.01,.1,;-5.86,-1.2,;-6.64,-2.53,;-8.18,-2.53,;-8.95,-1.18,;-8.16,.13,;-6.64,.13,;-5.86,1.48,;-6.63,2.82,;-6.63,4.36,;-7.97,3.59,;6.48,1.4,;5.71,2.72,;6.49,4.07,;8.04,4.07,;9.08,5.21,;10.49,4.57,;10.32,3.04,;8.8,2.72,;8.04,1.4,)| InChI=1S/C27H34N2O5S/c30-35(31,23-11-12-26-27(17-23)33-18-32-26)28-20-5-7-21(8-6-20)29-15-13-19(14-16-29)24-3-1-2-4-25(24)34-22-9-10-22/h1-4,11-12,17,19-22,28H,5-10,13-16,18H2 ZIIYCNPQTIYWFF-UHFFFAOYSA-N 50213517 N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzo[d][1,3]dioxole-5-sulfonamide::CHEMBL389104 Alpha-1D adrenergic receptor Homo sapiens 13 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213517&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 44426404 104088866 CHEMBL389104 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387074 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)F |wU:17.21,14.14,(10.25,-37,;8.71,-36.99,;7.93,-38.32,;6.37,-38.32,;5.6,-39.66,;6.36,-40.99,;7.93,-40.99,;8.69,-39.66,;10.23,-39.67,;10.99,-41.01,;5.59,-42.33,;4.27,-41.57,;6.95,-43.11,;4.84,-43.64,;3.26,-43.64,;2.5,-44.96,;.98,-44.96,;.21,-43.6,;.97,-42.29,;2.51,-42.33,;-1.36,-43.6,;-2.13,-44.93,;-3.66,-44.93,;-4.43,-43.59,;-3.66,-42.25,;-2.12,-42.29,;-5.98,-43.59,;-6.76,-44.92,;-8.3,-44.92,;-9.07,-43.58,;-8.29,-42.25,;-6.76,-42.25,;-5.98,-40.91,;-6.76,-39.58,;-5.99,-38.24,;-6.76,-36.91,;-4.45,-38.24,)| InChI=1S/C27H36F2N2O5S/c1-34-25-12-11-22(17-26(25)35-2)37(32,33)30-20-7-9-21(10-8-20)31-15-13-19(14-16-31)23-5-3-4-6-24(23)36-18-27(28)29/h3-6,11-12,17,19-21,27,30H,7-10,13-16,18H2,1-2H3 QLLKZBYEHJGRHK-UHFFFAOYSA-N 50213523 N-((1s,4s)-4-(4-(2-(2,2-difluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL387833 D(2) dopamine receptor Homo sapiens 276 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213523&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857862 104088872 CHEMBL387833 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387075 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:15.19,wD:12.12,(31.74,-46.23,;30.97,-44.89,;31.73,-43.57,;30.98,-42.22,;29.42,-42.22,;28.65,-40.89,;28.65,-43.57,;29.41,-44.89,;28.64,-46.24,;27.32,-45.47,;30,-47.01,;27.88,-47.54,;26.31,-47.54,;25.55,-46.24,;24.01,-46.19,;23.25,-47.51,;24.03,-48.86,;25.55,-48.86,;21.68,-47.51,;20.91,-48.84,;19.39,-48.84,;18.61,-47.49,;19.38,-46.16,;20.92,-46.19,;17.06,-47.49,;16.28,-48.83,;14.74,-48.83,;13.97,-47.48,;14.76,-46.16,;16.28,-46.16,;17.06,-44.82,;16.29,-43.48,;17.06,-42.15,;17.82,-40.8,;18.39,-42.91,;15.72,-41.39,)| InChI=1S/C25H29ClF4N2O3S/c26-18-5-10-22(27)24(15-18)36(33,34)31-19-6-8-20(9-7-19)32-13-11-17(12-14-32)21-3-1-2-4-23(21)35-16-25(28,29)30/h1-5,10,15,17,19-20,31H,6-9,11-14,16H2 HNTIGZIKHBPAFD-UHFFFAOYSA-N 50213535 5-chloro-2-fluoro-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228494 D(2) dopamine receptor Homo sapiens 37 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213535&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857793 104088884 CHEMBL228494 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387076 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:15.19,12.12,(9.95,-45.7,;9.18,-44.37,;9.94,-43.03,;9.15,-41.7,;7.6,-41.72,;6.82,-40.4,;6.85,-43.06,;7.63,-44.38,;6.87,-45.72,;5.52,-44.99,;8.22,-46.47,;6.15,-47.08,;4.62,-47.14,;3.89,-48.5,;2.36,-48.56,;1.54,-47.26,;2.25,-45.9,;3.79,-45.84,;.01,-47.32,;-.71,-48.68,;-2.24,-48.74,;-3.07,-47.44,;-2.36,-46.08,;-.82,-46.02,;-4.61,-47.51,;-5.32,-48.88,;-6.86,-48.95,;-7.68,-47.64,;-6.98,-46.28,;-5.44,-46.21,;-4.74,-44.84,;-5.57,-43.54,;-5.64,-42,;-6.94,-42.83,)| InChI=1S/C26H32ClFN2O3S/c27-19-5-12-24(28)26(17-19)34(31,32)29-20-6-8-21(9-7-20)30-15-13-18(14-16-30)23-3-1-2-4-25(23)33-22-10-11-22/h1-5,12,17-18,20-22,29H,6-11,13-16H2 LVDRNYWTLKUNNT-UHFFFAOYSA-N 50213538 5-chloro-N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-fluorobenzenesulfonamide::CHEMBL228280 Alpha-1B adrenergic receptor Homo sapiens 107 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213538&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857711 104088887 CHEMBL228280 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387077 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:15.19,wD:12.12,(31.74,-46.23,;30.97,-44.89,;31.73,-43.57,;30.98,-42.22,;29.42,-42.22,;28.65,-40.89,;28.65,-43.57,;29.41,-44.89,;28.64,-46.24,;27.32,-45.47,;30,-47.01,;27.88,-47.54,;26.31,-47.54,;25.55,-46.24,;24.01,-46.19,;23.25,-47.51,;24.03,-48.86,;25.55,-48.86,;21.68,-47.51,;20.91,-48.84,;19.39,-48.84,;18.61,-47.49,;19.38,-46.16,;20.92,-46.19,;17.06,-47.49,;16.28,-48.83,;14.74,-48.83,;13.97,-47.48,;14.76,-46.16,;16.28,-46.16,;17.06,-44.82,;16.29,-43.48,;17.06,-42.15,;17.82,-40.8,;18.39,-42.91,;15.72,-41.39,)| InChI=1S/C25H29ClF4N2O3S/c26-18-5-10-22(27)24(15-18)36(33,34)31-19-6-8-20(9-7-19)32-13-11-17(12-14-32)21-3-1-2-4-23(21)35-16-25(28,29)30/h1-5,10,15,17,19-20,31H,6-9,11-14,16H2 HNTIGZIKHBPAFD-UHFFFAOYSA-N 50213535 5-chloro-2-fluoro-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228494 Alpha-1A adrenergic receptor Homo sapiens 4.8 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213535&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857793 104088884 CHEMBL228494 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387078 FC(F)(F)COc1ccccc1C1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc2OCCOc2c1 |wU:18.19,wD:21.26,(18.05,-19.16,;17.29,-20.51,;18.63,-21.27,;15.95,-19.75,;16.52,-21.84,;17.3,-23.18,;16.52,-24.52,;15,-24.52,;14.21,-25.84,;14.98,-27.19,;16.52,-27.19,;17.3,-25.85,;18.85,-25.85,;19.62,-27.2,;21.15,-27.2,;21.92,-25.87,;21.16,-24.55,;19.62,-24.52,;23.49,-25.87,;24.25,-24.55,;25.78,-24.59,;26.54,-25.9,;25.78,-27.22,;24.26,-27.22,;28.12,-25.9,;28.87,-24.6,;27.55,-23.83,;30.23,-25.37,;29.64,-23.25,;28.88,-21.93,;29.65,-20.58,;31.21,-20.58,;31.99,-19.25,;33.53,-19.26,;34.29,-20.6,;33.51,-21.93,;31.96,-21.93,;31.2,-23.25,)| InChI=1S/C27H33F3N2O5S/c28-27(29,30)18-37-24-4-2-1-3-23(24)19-11-13-32(14-12-19)21-7-5-20(6-8-21)31-38(33,34)22-9-10-25-26(17-22)36-16-15-35-25/h1-4,9-10,17,19-21,31H,5-8,11-16,18H2 PPAIEDLGYFCKEB-UHFFFAOYSA-N 50213527 N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide::CHEMBL228390 Alpha-1D adrenergic receptor Homo sapiens 26 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213527&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857791 104088876 CHEMBL228390 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387079 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:15.19,12.12,(8.56,-46.34,;7.79,-45.01,;8.56,-43.69,;7.8,-42.34,;6.24,-42.34,;5.47,-41.01,;5.47,-43.69,;6.23,-45.01,;5.46,-46.35,;4.14,-45.59,;6.82,-47.13,;4.71,-47.66,;3.13,-47.66,;2.37,-48.98,;.85,-48.98,;.08,-47.63,;.84,-46.31,;2.37,-46.35,;-1.49,-47.63,;-2.26,-48.96,;-3.79,-48.96,;-4.56,-47.61,;-3.79,-46.28,;-2.26,-46.31,;-6.12,-47.61,;-6.89,-48.95,;-8.43,-48.95,;-9.2,-47.6,;-8.42,-46.28,;-6.89,-46.28,;-6.12,-44.93,;-6.89,-43.6,;-6.12,-42.27,;-5.36,-40.92,;-4.78,-43.03,;-7.46,-41.5,)| InChI=1S/C25H29ClF4N2O3S/c26-18-5-10-22(27)24(15-18)36(33,34)31-19-6-8-20(9-7-19)32-13-11-17(12-14-32)21-3-1-2-4-23(21)35-16-25(28,29)30/h1-5,10,15,17,19-20,31H,6-9,11-14,16H2 HNTIGZIKHBPAFD-UHFFFAOYSA-N 50213529 5-chloro-2-fluoro-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228445 Alpha-1D adrenergic receptor Homo sapiens 0.98 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213529&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857793 104088878 CHEMBL228445 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387080 FC(F)(F)COc1ccccc1C1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc2OCCOc2c1 |wU:18.19,21.26,(-5.05,-19.16,;-5.81,-20.51,;-4.47,-21.27,;-7.15,-19.75,;-6.58,-21.84,;-5.8,-23.18,;-6.58,-24.52,;-8.1,-24.52,;-8.89,-25.84,;-8.12,-27.19,;-6.58,-27.19,;-5.8,-25.85,;-4.25,-25.85,;-3.48,-27.2,;-1.95,-27.2,;-1.18,-25.87,;-1.94,-24.55,;-3.48,-24.52,;.39,-25.87,;1.16,-27.22,;2.68,-27.22,;3.44,-25.9,;2.68,-24.59,;1.15,-24.55,;5.02,-25.9,;5.77,-24.6,;4.45,-23.83,;7.13,-25.37,;6.54,-23.25,;5.78,-21.93,;6.55,-20.58,;8.11,-20.58,;8.89,-19.25,;10.43,-19.26,;11.19,-20.6,;10.41,-21.93,;8.86,-21.93,;8.1,-23.25,)| InChI=1S/C27H33F3N2O5S/c28-27(29,30)18-37-24-4-2-1-3-23(24)19-11-13-32(14-12-19)21-7-5-20(6-8-21)31-38(33,34)22-9-10-25-26(17-22)36-16-15-35-25/h1-4,9-10,17,19-21,31H,5-8,11-16,18H2 PPAIEDLGYFCKEB-UHFFFAOYSA-N 50213516 N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide::CHEMBL439197 Alpha-1A adrenergic receptor Homo sapiens 4 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213516&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857791 104088865 CHEMBL439197 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387081 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCCF |wU:17.21,14.14,(9.78,-22.9,;8.24,-22.89,;7.46,-24.22,;5.9,-24.22,;5.13,-25.56,;5.89,-26.89,;7.45,-26.89,;8.21,-25.57,;9.75,-25.58,;10.52,-26.91,;5.12,-28.23,;3.8,-27.47,;6.48,-29.01,;4.36,-29.54,;2.79,-29.54,;2.03,-30.86,;.51,-30.86,;-.27,-29.51,;.5,-28.19,;2.03,-28.23,;-1.84,-29.51,;-2.6,-30.83,;-4.13,-30.83,;-4.91,-29.49,;-4.14,-28.16,;-2.6,-28.19,;-6.46,-29.49,;-7.23,-30.83,;-8.77,-30.83,;-9.55,-29.48,;-8.76,-28.16,;-7.24,-28.16,;-6.46,-26.81,;-7.23,-25.48,;-6.46,-24.14,;-7.23,-22.81,)| InChI=1S/C27H37FN2O5S/c1-33-26-12-11-23(19-27(26)34-2)36(31,32)29-21-7-9-22(10-8-21)30-16-13-20(14-17-30)24-5-3-4-6-25(24)35-18-15-28/h3-6,11-12,19-22,29H,7-10,13-18H2,1-2H3 NZOIFXLLVJGITJ-UHFFFAOYSA-N 50213536 N-((1s,4s)-4-(4-(2-(2-fluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL538397 Alpha-1D adrenergic receptor Homo sapiens 5.5 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213536&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857861 104088885 CHEMBL538397 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387082 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccc(F)cc1OC(C)C |wU:17.21,wD:14.14,(30.8,4.05,;29.26,4.06,;28.48,2.73,;26.92,2.73,;26.15,1.38,;26.91,.06,;28.47,.06,;29.23,1.38,;30.77,1.37,;31.54,.03,;26.14,-1.29,;24.82,-.52,;27.5,-2.06,;25.39,-2.59,;23.81,-2.59,;23.05,-1.28,;21.52,-1.24,;20.76,-2.56,;21.53,-3.91,;23.05,-3.91,;19.19,-2.56,;18.42,-3.89,;16.89,-3.89,;16.12,-2.54,;16.89,-1.21,;18.43,-1.24,;14.57,-2.54,;13.79,-3.88,;12.25,-3.88,;11.48,-2.53,;9.94,-2.52,;12.27,-1.21,;13.79,-1.21,;14.57,.13,;13.79,1.47,;14.56,2.8,;12.25,1.47,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-27-17-21(29)5-11-25(27)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-26(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 FEQSGCAJKJDTEE-UHFFFAOYSA-N 50213508 N-((1r,4r)-4-(4-(4-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228658 D(2) dopamine receptor Homo sapiens 104 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213508&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857863 104088857 CHEMBL228658 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50387083 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:16.20,13.13,(10.72,-35.85,;9.18,-35.85,;8.41,-34.51,;9.17,-33.19,;8.41,-31.84,;6.86,-31.84,;6.08,-30.51,;6.08,-33.19,;6.85,-34.51,;6.08,-35.86,;4.75,-35.09,;7.44,-36.63,;5.32,-37.16,;3.75,-37.16,;2.99,-38.48,;1.47,-38.48,;.69,-37.13,;1.45,-35.81,;2.99,-35.86,;-.88,-37.13,;-1.65,-38.46,;-3.17,-38.46,;-3.95,-37.11,;-3.18,-35.78,;-1.64,-35.81,;-5.5,-37.11,;-6.28,-38.45,;-7.82,-38.45,;-8.59,-37.1,;-7.8,-35.78,;-6.28,-35.78,;-5.5,-34.44,;-6.27,-33.1,;-5.5,-31.77,;-4.75,-30.43,;-4.17,-32.53,;-6.84,-31.01,)| InChI=1S/C26H32ClF3N2O4S/c1-35-24-11-6-19(27)16-25(24)37(33,34)31-20-7-9-21(10-8-20)32-14-12-18(13-15-32)22-4-2-3-5-23(22)36-17-26(28,29)30/h2-6,11,16,18,20-21,31H,7-10,12-15,17H2,1H3 WDZOSSNSOBKEMP-UHFFFAOYSA-N 50213522 5-chloro-2-methoxy-N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL442059 Alpha-1A adrenergic receptor Homo sapiens 6.2 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213522&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857792 104088871 CHEMBL442059 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387084 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:15.19,wD:12.12,(31.96,-44.68,;31.18,-43.35,;31.94,-42.01,;31.16,-40.68,;29.61,-40.69,;28.82,-39.37,;28.85,-42.04,;29.64,-43.36,;28.88,-44.7,;27.52,-43.96,;30.22,-45.44,;28.16,-46.06,;26.62,-46.12,;25.8,-44.81,;24.25,-44.87,;23.54,-46.24,;24.37,-47.54,;25.9,-47.48,;22.01,-46.29,;21.29,-47.66,;19.76,-47.72,;18.93,-46.42,;19.64,-45.05,;21.18,-44.99,;17.39,-46.49,;16.68,-47.85,;15.14,-47.92,;14.31,-46.62,;15.02,-45.26,;16.56,-45.18,;17.26,-43.81,;16.43,-42.52,;16.36,-40.99,;15.06,-41.82,)| InChI=1S/C26H32ClFN2O3S/c27-19-5-12-24(28)26(17-19)34(31,32)29-20-6-8-21(9-7-20)30-15-13-18(14-16-30)23-3-1-2-4-25(23)33-22-10-11-22/h1-5,12,17-18,20-22,29H,6-11,13-16H2 LVDRNYWTLKUNNT-UHFFFAOYSA-N 50213510 5-chloro-N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-fluorobenzenesulfonamide::CHEMBL228332 Alpha-1B adrenergic receptor Homo sapiens 337 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=11048&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213510&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857711 104088859 CHEMBL228332 1 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 50387085 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1cc(F)ccc1OC(C)C |wU:17.21,wD:14.14,(32.28,-7.61,;30.74,-7.6,;29.96,-8.93,;28.4,-8.93,;27.63,-10.28,;28.39,-11.6,;29.95,-11.6,;30.71,-10.28,;32.25,-10.29,;33.01,-11.63,;27.62,-12.95,;26.3,-12.18,;28.98,-13.72,;26.86,-14.25,;25.29,-14.25,;24.53,-12.94,;23,-12.9,;22.23,-14.22,;23.01,-15.57,;24.53,-15.57,;20.67,-14.22,;19.9,-15.55,;18.37,-15.55,;17.6,-14.2,;18.37,-12.87,;19.9,-12.9,;16.04,-14.2,;15.27,-15.54,;13.73,-15.54,;12.96,-16.87,;12.96,-14.19,;13.74,-12.87,;15.27,-12.87,;16.04,-11.52,;15.27,-10.19,;16.04,-8.86,;13.73,-10.19,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-26-11-5-21(29)17-25(26)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-27(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 AEJCTJSNUNXYQL-UHFFFAOYSA-N 50213539 N-((1r,4r)-4-(4-(5-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL390473 Alpha-1A adrenergic receptor Homo sapiens 43 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213539&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857864 104088888 CHEMBL390473 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387086 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccc(F)cc1OC(C)C |wU:17.21,14.14,(10.4,4.9,;8.86,4.91,;8.09,3.58,;6.53,3.58,;5.76,2.24,;6.52,.91,;8.08,.91,;8.84,2.23,;10.38,2.22,;11.14,.89,;5.75,-.43,;4.43,.33,;7.11,-1.21,;4.99,-1.74,;3.42,-1.74,;2.66,-3.06,;1.14,-3.06,;.36,-1.71,;1.13,-.39,;2.66,-.43,;-1.2,-1.71,;-1.97,-3.03,;-3.5,-3.03,;-4.27,-1.69,;-3.5,-.36,;-1.97,-.39,;-5.83,-1.69,;-6.6,-3.02,;-8.14,-3.02,;-8.91,-1.68,;-10.45,-1.66,;-8.13,-.36,;-6.6,-.36,;-5.83,.99,;-6.6,2.32,;-5.83,3.66,;-8.14,2.32,)| InChI=1S/C28H39FN2O5S/c1-19(2)36-27-17-21(29)5-11-25(27)20-13-15-31(16-14-20)23-8-6-22(7-9-23)30-37(32,33)24-10-12-26(34-3)28(18-24)35-4/h5,10-12,17-20,22-23,30H,6-9,13-16H2,1-4H3 FEQSGCAJKJDTEE-UHFFFAOYSA-N 50213532 N-((1s,4s)-4-(4-(4-fluoro-2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide::CHEMBL228608 Alpha-1A adrenergic receptor Homo sapiens 16 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213532&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857863 104088881 CHEMBL228608 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387087 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:16.20,wD:13.13,(33.93,-35.76,;32.39,-35.76,;31.62,-34.43,;32.38,-33.1,;31.63,-31.76,;30.07,-31.76,;29.3,-30.42,;29.3,-33.1,;30.06,-34.43,;29.29,-35.77,;27.97,-35.01,;30.65,-36.55,;28.53,-37.08,;26.96,-37.08,;26.2,-35.77,;24.67,-35.73,;23.9,-37.04,;24.68,-38.4,;26.2,-38.4,;22.33,-37.04,;21.57,-38.37,;20.04,-38.37,;19.26,-37.03,;20.03,-35.69,;21.57,-35.73,;17.71,-37.03,;16.94,-38.36,;15.4,-38.36,;14.62,-37.01,;15.41,-35.69,;16.93,-35.69,;17.71,-34.35,;16.94,-33.02,;17.71,-31.68,;18.47,-30.34,;19.05,-32.44,;16.37,-30.92,)| InChI=1S/C26H32ClF3N2O4S/c1-35-24-11-6-19(27)16-25(24)37(33,34)31-20-7-9-21(10-8-20)32-14-12-18(13-15-32)22-4-2-3-5-23(22)36-17-26(28,29)30/h2-6,11,16,18,20-21,31H,7-10,12-15,17H2,1H3 WDZOSSNSOBKEMP-UHFFFAOYSA-N 50213515 5-chloro-2-methoxy-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL390192 Alpha-1A adrenergic receptor Homo sapiens 10 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213515&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857792 104088864 CHEMBL390192 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 50387088 COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,wD:14.14,(31.88,-7.8,;30.34,-7.79,;29.56,-9.12,;28,-9.12,;27.23,-10.47,;27.99,-11.79,;29.55,-11.79,;30.32,-10.47,;31.86,-10.48,;32.62,-11.82,;27.22,-13.13,;25.9,-12.37,;28.58,-13.91,;26.47,-14.44,;24.89,-14.44,;24.14,-13.13,;22.6,-13.09,;21.84,-14.41,;22.61,-15.76,;24.13,-15.76,;20.27,-14.41,;19.5,-15.73,;17.98,-15.73,;17.2,-14.39,;17.97,-13.06,;19.51,-13.09,;15.65,-14.39,;14.87,-15.72,;13.33,-15.72,;12.56,-14.38,;13.35,-13.06,;14.87,-13.06,;15.65,-11.71,;14.88,-10.38,;15.64,-9.04,;16.4,-7.7,;16.98,-9.81,;14.31,-8.28,)| InChI=1S/C27H35F3N2O5S/c1-35-25-12-11-22(17-26(25)36-2)38(33,34)31-20-7-9-21(10-8-20)32-15-13-19(14-16-32)23-5-3-4-6-24(23)37-18-27(28,29)30/h3-6,11-12,17,19-21,31H,7-10,13-16,18H2,1-2H3 USIWFTPEBGPOSA-UHFFFAOYSA-N 50213537 3,4-dimethoxy-N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide::CHEMBL228389 Alpha-1D adrenergic receptor Homo sapiens 23 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000208&target=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213537&enzyme=Alpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857709 104088886 CHEMBL228389 1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 50387089 Fc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC1CC1 |wU:15.19,12.12,(9.95,-45.7,;9.18,-44.37,;9.94,-43.03,;9.15,-41.7,;7.6,-41.72,;6.82,-40.4,;6.85,-43.06,;7.63,-44.38,;6.87,-45.72,;5.52,-44.99,;8.22,-46.47,;6.15,-47.08,;4.62,-47.14,;3.89,-48.5,;2.36,-48.56,;1.54,-47.26,;2.25,-45.9,;3.79,-45.84,;.01,-47.32,;-.71,-48.68,;-2.24,-48.74,;-3.07,-47.44,;-2.36,-46.08,;-.82,-46.02,;-4.61,-47.51,;-5.32,-48.88,;-6.86,-48.95,;-7.68,-47.64,;-6.98,-46.28,;-5.44,-46.21,;-4.74,-44.84,;-5.57,-43.54,;-5.64,-42,;-6.94,-42.83,)| InChI=1S/C26H32ClFN2O3S/c27-19-5-12-24(28)26(17-19)34(31,32)29-20-6-8-21(9-7-20)30-15-13-18(14-16-30)23-3-1-2-4-25(23)33-22-10-11-22/h1-5,12,17-18,20-22,29H,6-11,13-16H2 LVDRNYWTLKUNNT-UHFFFAOYSA-N 50213538 5-chloro-N-((1s,4s)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-fluorobenzenesulfonamide::CHEMBL228280 D(2) dopamine receptor Homo sapiens 187 ChEMBL 10.1016/j.bmcl.2007.04.098 10.7270/Q2639PF1 17517507 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA 6/22/2007 11/10/2009 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50213538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50213538&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11857711 104088887 CHEMBL228280 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5